<?xml version="1.0" encoding="utf-8"?>
<Bundle xmlns="http://hl7.org/fhir">
    <id value="bundle-ibrance75-100-125" />
    <meta>
    <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi" />
    </meta>
    <identifier>
        <system value="https://www.fda.gov/" />
        <value value="ibrance" />
    </identifier>
    <type value="document" />
    <timestamp value="2024-12-27T00:00:00Z" />
    <entry>
        <fullUrl value="Composition/compositionusen" />
        <resource>
            <Composition>
                <id value="compositionusen" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi" />
                </meta>
                <language value="en" />
                <text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">
                        <p>These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. </p>
                        <p>IBRANCE<sup>Â®</sup> (palbociclib) capsules, for oral use </p>
                        <p>Initial U.S. Approval: 2015</p>
                    </div>
                </text>
                <version value="16" />
                <contained>
                    <Binary>
                        <id value="ibrance-01" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-02" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-03" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-04" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-05" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-06" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-07" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-08" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <contained>
                    <Binary>
                        <id value="ibrance-09" />
                        <contentType value="image/jpg" />
                        <data
                            value="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" />
                    </Binary>
                </contained>
                <identifier>
                    <system value="https://www.fda.gov/" />
                    <value value="2de9790e-3eb6-49ca-a35b-7b42c569f794" />
                </identifier>
                <status value="final" />
                <type>
                    <coding>
                        <system value="http://loinc.org" />
                        <code value="34391-3" />
                        <display value="HUMAN PRESCRIPTION DRUG LABEL" />
                    </coding>
                </type>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <date value="2024-12-27T00:00:00Z" />
                <author>
                    <reference value="Organization/134489525" />
                </author>
                <title value="Drug Label for IBRANCE (palbociclib) capsules" />
                <section id="4a7f4ea7-edd4-42b9-8f79-20cbdcfac3a5">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_9e4d1989-7184-46ce-a222-1b221d893f7d" />
                    </extension>
                    <code>
                        <coding>
							<system value="http://loinc.org"/>
							<code value="43683-2"/>
							<display value="RECENT MAJOR CHANGES SECTION"/>
						</coding>
                    </code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <table width="100%">
                                    <colgroup span="2">
                                        <col width="85%" />
                                        <col width="15%" />
                                    </colgroup>
                                    <tbody>
                                        <tr>
                                            <td style="text-align: left; text-align: left; ">
                                                <p>Indications and Usage (<a href="#ID_RefS1">1</a>)</p>
                                            </td>
                                            <td style="text-align: center; text-align: center; " align="center">
                                                <p style="text-align: center; ">12/2022</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="text-align: left; text-align: left; ">
                                                <p>Dosage and Administration (<a href="#ID_RefS2.1">2.1</a>)</p>
                                            </td>
                                            <td style="text-align: center; text-align: center; " align="center">
                                                <p style="text-align: center; ">12/2022</p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="50d48d6d-036f-4b2a-843e-390340f8c6b9">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S1" />
                    </extension>
                    <title value="1 INDICATIONS AND USAGE" />
                    <code>
                        <coding>
							<system value="http://loinc.org"/>
							<code value="34067-9"/>
							<display value="INDICATIONS &amp; USAGE SECTION"/>
						</coding>
                    </code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>IBRANCE is a kinase inhibitor indicated for the treatment of adult patients with
                                    hormone receptor (HR)-positive, human epidermal growth factor receptor 2
                                    (HER2)-negative advanced or metastatic breast cancer in combination with:</p>
                                <ul>
                                    <li>an aromatase inhibitor as initial endocrine-based therapy (<a
                                            href="#ID_RefS1">1</a>); or</li>
                                    <li>fulvestrant in patients with disease progression following endocrine therapy.
                                        (<a href="#ID_RefS1">1</a>)</li>
                                </ul>
                            </div>
                            <div style="narrative">
                                <p>IBRANCE is indicated for the treatment of adult patients with hormone receptor
                                    (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or
                                    metastatic breast cancer in combination with:</p>
                                <ul>
                                    <li id="_RefS1">an aromatase inhibitor as initial endocrine-based therapy; or</li>
                                    <li>fulvestrant in patients with disease progression following endocrine therapy.
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="0798fd83-eca9-4dc5-960f-475b14fefab2">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S2" />
                    </extension>
                    <title value="2 DOSAGE AND ADMINISTRATION" />
                    <code>
                        <coding>
							<system value="http://loinc.org"/>
							<code value="34068-7"/>
							<display value="DOSAGE &amp; ADMINISTRATION SECTION"/>
						</coding>
                    </code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>IBRANCE capsules are taken orally with food in combination with an aromatase
                                    inhibitor or fulvestrant. (<a href="#S2.2">2</a>)</p>
                                <ul>
                                    <li>Recommended starting dose: 125 mg once daily taken with food for 21 days
                                        followed by 7 days off treatment. (<a href="#ID_RefS2.1">2.1</a>)</li>
                                    <li>Dosing interruption and/or dose reductions are recommended based on individual
                                        safety and tolerability. (<a href="#ID_RefS2.2">2.2</a>)</li>
                                </ul>
                            </div>
                        </div>
                    </text>
                    <section id="3df707b5-7811-412e-81c7-ac3cf3ed0d68">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S2.1" />
                        </extension>
                        <title value="2.1 Recommended Dose and Schedule" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The recommended dose of IBRANCE is a 125 mg capsule taken orally once daily for
                                        21 consecutive days followed by 7 days off treatment to comprise a complete
                                        cycle of 28 days. IBRANCE should be taken with food <em>[see <a
                                                href="#S12.3">Clinical Pharmacology (12.3)</a>]</em>.</p>
                                    <p>Administer the recommended dose of an aromatase inhibitor when given with
                                        IBRANCE. Please refer to the Full Prescribing Information for the aromatase
                                        inhibitor being used.</p>
                                    <p>When given with IBRANCE, the recommended dose of fulvestrant is 500 mg
                                        administered on Days 1, 15, 29, and once monthly thereafter. Please refer to the
                                        Full Prescribing Information of fulvestrant.</p>
                                    <p>Patients should be encouraged to take their dose of IBRANCE at approximately the
                                        same time each day.</p>
                                    <p>If the patient vomits or misses a dose, an additional dose should not be taken.
                                        The next prescribed dose should be taken at the usual time. IBRANCE capsules
                                        should be swallowed whole (do not chew, crush, or open them prior to
                                        swallowing). Capsules should not be ingested if they are broken, cracked, or
                                        otherwise not intact.</p>
                                    <p>Pre/perimenopausal women treated with the combination IBRANCE plus <span>an
                                            aromatase inhibitor or </span>fulvestrant therapy should also be treated
                                        with luteinizing hormone-releasing hormone (LHRH) agonists according to current
                                        clinical practice standards.</p>
                                    <p>For men treated with combination IBRANCE plus aromatase inhibitor therapy,
                                        consider treatment with an LHRH agonist according to current clinical practice
                                        standards.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="02299b20-59f0-4e22-b0b7-1a4ced375ef9">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S2.2" />
                        </extension>
                        <title value="2.2 Dose Modification" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The recommended dose modifications for adverse reactions are listed in Tables 1,
                                        2, and 3.</p>
                                    <table width="70%">
                                        <caption>Table 1. Recommended Dose Modification for Adverse Reactions</caption>
                                        <colgroup span="2">
                                            <col width="38%" />
                                            <col width="43%" />
                                        </colgroup>
                                        <thead>
                                            <tr>
                                                <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                    align="">
                                                    <strong>Dose Level</strong>
                                                </td>
                                                <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                    align="">
                                                    <strong>Dose</strong>
                                                </td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                    <p>Recommended starting dose</p>
                                                </td>
                                                <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                    align="center">
                                                    <p style="text-align: center; ">125 mg/day</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                    <p>First dose reduction</p>
                                                </td>
                                                <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                    align="center">
                                                    <p style="text-align: center; ">100 mg/day</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                    <p>Second dose reduction</p>
                                                </td>
                                                <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                    align="center">
                                                    <p style="text-align: center; ">75 mg/day<a href="#_RefID0EWWAE"
                                                            id="ID0EY4BG" name="foot-ref-_RefID0EWWAE">
                                                            <sup>1</sup>
                                                        </a>
                                                    </p>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                    <p><sup>
                                            <a name="_RefID0EWWAE" href="#foot-ref-_RefID0EWWAE">1</a>
                                        </sup>If further
                                        dose reduction below 75 mg/day is required, discontinue.</p>
                                    <table width="80%">
                                        <caption>Table 2. Dose Modification and Management â Hematologic Toxicities<a
                                                href="#_RefID0E2WAE" id="ID0EDOAI" name="foot-ref-_RefID0E2WAE">
                                                <sup>1</sup>
                                            </a></caption>
                                        <colgroup span="2">
                                            <col width="19%" />
                                            <col width="73%" />
                                        </colgroup>
                                        <tfoot>
                                            <tr>
                                                <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                    colspan="2">Grading according to CTCAE 4.0.<br />CTCAE=Common
                                                    Terminology Criteria for Adverse Events; LLN=lower limit of normal.
                                                </td>
                                            </tr>
                                        </tfoot>
                                        <tbody>
                                            <tr>
                                                <td colspan="2"
                                                    style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: left; ">
                                                    <p>Monitor complete blood counts prior to the start of IBRANCE
                                                        therapy and at the beginning of each cycle, as well as on Day 15
                                                        of the first 2 cycles, and as clinically indicated.<br />For
                                                        patients who experience a maximum of Grade 1 or 2 neutropenia in
                                                        the first 6 cycles, monitor complete blood counts for subsequent
                                                        cycles every 3 months, prior to the beginning of a cycle and as
                                                        clinically indicated.</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center; border-right: solid; border-left: solid; border-bottom: solid; text-align: center; "
                                                    align="center">
                                                    <p style="text-align: center; ">
                                                        <strong>CTCAE Grade</strong>
                                                    </p>
                                                </td>
                                                <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                    align="center">
                                                    <p style="text-align: center; ">
                                                        <strong>Dose Modifications</strong>
                                                    </p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                    <p>Grade 1 or 2</p>
                                                </td>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                    <p>No dose adjustment is required.</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                    <p>Grade 3</p>
                                                </td>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                    <p><span style="text-decoration: underline; ">Day 1 of
                                                            cycle</span>:<br />Withhold IBRANCE, repeat complete blood
                                                        count monitoring within 1 week. When recovered to Grade â¤2,
                                                        start the next cycle at the <em>same dose</em>.<br /><span
                                                            style="text-decoration: underline; ">Day 15 of first 2
                                                            cycles</span>:<br />If Grade 3 on Day 15, continue IBRANCE
                                                        at current dose to complete cycle and repeat complete blood
                                                        count on Day 22.<br />If Grade 4 on Day 22, see dose
                                                        modification guidelines below.<br />Consider dose reduction in
                                                        cases of prolonged (&gt;1 week) recovery from Grade 3
                                                        neutropenia or recurrent Grade 3 neutropenia on Day 1 of
                                                        subsequent cycles.</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                    <p>Grade 3 neutropenia<a href="#_RefID0EHZAE" id="ID0E3OAI"
                                                            name="foot-ref-_RefID0EHZAE">
                                                            <sup>1</sup>
                                                        </a> with fever
                                                        â¥38.5 ÂºC and/or infection</p>
                                                </td>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                    <p><span style="text-decoration: underline; ">At any
                                                            time</span>:<br />Withhold IBRANCE until recovery to Grade
                                                        â¤2.<br />Resume at the <em>next lower dose</em>.</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                    <p>Grade 4</p>
                                                </td>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                    <p><span style="text-decoration: underline; ">At any
                                                            time</span>:<br />Withhold IBRANCE until recovery to Grade
                                                        â¤2.<br />Resume at the <em>next lower dose</em>.</p>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                    <p><sup>
                                            <a name="_RefID0E2WAE" href="#foot-ref-_RefID0E2WAE">1</a>
                                        </sup>Table
                                        applies to all hematologic adverse reactions except lymphopenia (unless
                                        associated with clinical events, e.g., opportunistic infections).</p>
                                    <p><sup>
                                            <a name="_RefID0EHZAE" href="#foot-ref-_RefID0EHZAE">2</a>
                                        </sup>Absolute
                                        neutrophil count (ANC): Grade 1: ANC &lt; LLN - 1500/mm<sup>3</sup>; Grade 2:
                                        ANC 1000 - &lt;1500/mm<sup>3</sup>; Grade 3: ANC 500 - &lt;1000/mm<sup>3</sup>;
                                        Grade 4: ANC &lt;500/mm<sup>3</sup>.</p>
                                    <table width="70%">
                                        <caption>Table 3. Dose Modification and Management â Non-Hematologic Toxicities
                                        </caption>
                                        <colgroup span="2">
                                            <col width="36%" />
                                            <col width="45%" />
                                        </colgroup>
                                        <thead>
                                            <tr>
                                                <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                    align="">
                                                    <strong>CTCAE Grade</strong>
                                                </td>
                                                <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                    align="">
                                                    <strong>Dose Modifications</strong>
                                                </td>
                                            </tr>
                                        </thead>
                                        <tfoot>
                                            <tr>
                                                <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                    colspan="2">Grading according to CTCAE 4.0.<br />CTCAE=Common
                                                    Terminology Criteria for Adverse Events.</td>
                                            </tr>
                                        </tfoot>
                                        <tbody>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                    <p>Grade 1 or 2</p>
                                                </td>
                                                <td
                                                    style="text-align: left; border-right: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                    <p>No dose adjustment is required.</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                    <p>Grade â¥3 non-hematologic toxicity (if persisting despite optimal
                                                        medical treatment)</p>
                                                </td>
                                                <td
                                                    style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                    <p>Withhold until symptoms resolve to:</p>
                                                    <ul>
                                                        <li>Grade â¤1;</li>
                                                        <li>Grade â¤2 (if not considered a safety risk for the patient)
                                                        </li>
                                                    </ul>
                                                    <p>Resume at the <em>next lower dose</em>.</p>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                    <p>Permanently discontinue IBRANCE in patients with severe interstitial lung disease
                                        (ILD)/pneumonitis.</p>
                                    <p>Refer to the Full Prescribing Information for coadministered endocrine therapy
                                        dose adjustment guidelines in the event of toxicity and other relevant safety
                                        information or contraindications.</p>
                                </div>
                            </div>
                        </text>
                        <section id="43fbd4a1-8f15-4d65-a257-04df4a5741a3">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_459fbc93-4616-4552-9734-e5ca8265b9fc" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Dose Modifications for Use With Strong CYP3A Inhibitors</strong>
                                        </p>
                                        <p>Avoid concomitant use of strong CYP3A inhibitors and consider an alternative
                                            concomitant medication with no or minimal CYP3A inhibition. If patients must
                                            be coadministered a strong CYP3A inhibitor, reduce the IBRANCE dose to 75 mg
                                            once daily. If the strong inhibitor is discontinued, increase the IBRANCE
                                            dose (after 3 to 5 half-lives of the inhibitor) to the dose used prior to
                                            the initiation of the strong CYP3A inhibitor <em>[see <a href="#S7.1">Drug
                                                    Interactions (7.1)</a> and <a href="#ID_RefS12.3">Clinical
                                                    Pharmacology (12.3)</a>].</em></p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="5125ae38-021b-4930-a204-3ec15bbe4a9e">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_6c05ea7d-9c8c-46a6-89e6-292c285845b2" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Dose Modifications for Hepatic Impairment</strong>
                                        </p>
                                        <p>No dose adjustment is required for patients with mild or moderate hepatic
                                            impairment (Child-Pugh classes A and B). For patients with severe hepatic
                                            impairment (Child-Pugh class C), the recommended dose of IBRANCE is 75 mg
                                            once daily for 21 consecutive days followed by 7 days off treatment to
                                            comprise a complete cycle of 28 days <em>[see <a href="#ID_RefS8.6">Use in
                                                    Specific Populations (8.6)</a> and <a href="#S12.3">Clinical
                                                    Pharmacology (12.3)</a>].</em></p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                </section>
                <section id="1c9f8e9c-ba81-4f80-9e65-5f72dacd6b82">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S3" />
                    </extension>
                    <title value="3 DOSAGE FORMS AND STRENGTHS" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="43678-2"/>
							<display value="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>Capsules: 125 mg, 100 mg, and 75 mg. (<a href="#ID_RefS3">3</a>)</p>
                            </div>
                            <div style="narrative">
                                <p>125 mg capsules: opaque, hard gelatin capsules, size 0, with caramel cap and body,
                                    printed with white ink "Pfizer" on the cap, "PBC 125" on the body.</p>
                                <p>100 mg capsules: opaque,
                                    hard gelatin capsules, size 1, with caramel cap and light
                                    orange body, printed with white ink "Pfizer" on the cap, "PBC 100" on the
                                    body.</p>
                                <p>75 mg capsules: opaque, hard gelatin capsules, size 2, with light orange cap and
                                    body, printed with white ink "Pfizer" on the cap, "PBC 75" on the body.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="f062a2a0-4979-445b-ab97-489bb7a56663">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S4" />
                    </extension>
                    <title value="4 CONTRAINDICATIONS" />
                    <code>
                        <coding>
							<system value="http://loinc.org"/>
							<code value="34070-3"/>
							<display value="CONTRAINDICATIONS SECTION"/>
						</coding>
                    </code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>None. (<a href="#ID_RefS4">4</a>)</p>
                            </div>
                            <div style="narrative">
                                <p>None.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="2a75ea96-3dff-46cb-a3f5-561ec51d0984">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S5" />
                    </extension>
                    <title value="5 WARNINGS AND PRECAUTIONS" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="43685-7"/>
							<display value="WARNINGS AND PRECAUTIONS SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <ul>
                                    <li>Neutropenia: Monitor complete blood count prior to start of IBRANCE therapy and
                                        at the beginning of each cycle, as well as on Day 15 of the first 2 cycles, and
                                        as clinically indicated. (<a href="#ID_RefS2.2">2.2</a>, <a
                                            href="#ID_RefS5.1">5.1</a>)</li>
                                    <li>Interstitial Lung Disease (ILD)/Pneumonitis: Severe and fatal cases of
                                        ILD/pneumonitis have been reported. Monitor for pulmonary symptoms of
                                        ILD/pneumonitis. Interrupt IBRANCE immediately in patients with suspected
                                        ILD/pneumonitis. Permanently discontinue IBRANCE if severe ILD/pneumonitis
                                        occurs. (<a href="#ID_RefS5.2">5.2</a>)</li>
                                    <li>Embryo-Fetal Toxicity: IBRANCE can cause fetal harm. Advise patients of
                                        potential risk to a fetus and to use effective contraception. (<a
                                            href="#ID_RefS5.3">5.3</a>, <a href="#ID_RefS8.1">8.1</a>, <a
                                            href="#ID_RefS8.3">8.3</a>)</li>
                                </ul>
                            </div>
                        </div>
                    </text>
                    <section id="29ff946d-9b22-49f2-a3ae-2474b1ce14c1">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.1" />
                        </extension>
                        <title value="5.1 Neutropenia" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Neutropenia was the most frequently reported adverse reaction in PALOMA-2 with an
                                        incidence of 80% and PALOMA-3 with an incidence of 83%. A Grade â¥3 decrease in
                                        neutrophil counts was reported in 66% of patients receiving IBRANCE plus
                                        letrozole in PALOMA-2 and 66% of patients receiving IBRANCE plus fulvestrant in
                                        PALOMA-3. In PALOMA-2 and PALOMA-3, the median time to first episode of any
                                        grade neutropenia was 15 days and the median duration of Grade â¥3 neutropenia
                                        was 7 days <em>[see <a href="#ID_RefS6.1">Adverse Reactions (6.1)</a>]</em>.
                                    </p>
                                    <p>Monitor complete blood counts prior to starting IBRANCE therapy and at the
                                        beginning of each cycle, as well as on Day 15 of the first 2 cycles, and as
                                        clinically indicated. Dose interruption, dose reduction, or delay in starting
                                        treatment cycles is recommended for patients who develop Grade 3 or 4
                                        neutropenia <em>[see <a href="#ID_RefS2.2">Dosage and Administration
                                                (2.2)</a>]</em>. </p>
                                    <p>Febrile neutropenia has been reported in 1.8% of patients exposed to IBRANCE
                                        across PALOMA-2 and PALOMA-3. One death due to neutropenic sepsis was observed
                                        in PALOMA-3. Physicians should inform patients to promptly report any episodes
                                        of fever <em>[see <a href="#ID_RefS17">Patient Counseling Information
                                                (17)</a>]</em>. </p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="6aca2a50-a8c7-4fb2-8f01-1755db6d35b1">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.2" />
                        </extension>
                        <title value="5.2 Interstitial Lung Disease (ILD)/Pneumonitis" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Severe, life-threatening, or fatal interstitial lung disease (ILD) and/or
                                        pneumonitis can occur in patients treated with cyclin-dependent kinase 4/6
                                        (CDK4/6) inhibitors, including IBRANCE when taken in combination with endocrine
                                        therapy.</p>
                                    <p>Across clinical trials (PALOMA-1, PALOMA-2, PALOMA-3), 1.0% of IBRANCE-treated
                                        patients had ILD/pneumonitis of any grade, 0.1% had Grade 3 or 4 and no fatal
                                        cases were reported. Additional cases of ILD/pneumonitis have been observed in
                                        the postmarketing setting, with fatalities reported <em>[see <a
                                                href="#ID_RefS6.2">Adverse Reactions (6.2)</a>]</em>.</p>
                                    <p>Monitor patients for pulmonary symptoms indicative of ILD/pneumonitis (e.g.
                                        hypoxia, cough, dyspnea). In patients who have new or worsening respiratory
                                        symptoms and are suspected to have developed pneumonitis, interrupt IBRANCE
                                        immediately and evaluate the patient. Permanently discontinue IBRANCE in
                                        patients with severe ILD or pneumonitis <em>[see <a href="#ID_RefS2.2">Dosage
                                                and Administration (2.2)</a>]</em>.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="d2c6581f-33fe-411a-aa00-3f4765cc7186">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.3" />
                        </extension>
                        <title value="5.3 Embryo-Fetal Toxicity" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Based on findings from animal studies and its mechanism of action, IBRANCE can
                                        cause fetal harm when administered to a pregnant woman. In animal reproduction
                                        studies, administration of palbociclib to pregnant rats and rabbits during
                                        organogenesis resulted in embryo-fetal toxicity at maternal exposures that were
                                        â¥4 times the human clinical exposure based on area under the curve (AUC). Advise
                                        pregnant women of the potential risk to a fetus. Advise females of reproductive
                                        potential to use effective contraception during treatment with IBRANCE and for
                                        at least 3 weeks after the last dose <em>[see <a href="#ID_RefS8.1">Use in
                                                Specific Populations (8.1</a> and <a href="#ID_RefS8.3">8.3)</a> and <a
                                                href="#ID_RefS12.1">Clinical Pharmacology (12.1)</a>]</em>. </p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="412ad9d8-24e7-4ebb-8989-b92e871b2fa6">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S6" />
                    </extension>
                    <title value="6 ADVERSE REACTIONS" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="34084-4"/>
							<display value="ADVERSE REACTIONS SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>Most common adverse reactions (incidence â¥10%) were neutropenia, infections,
                                    leukopenia, fatigue, nausea, stomatitis, anemia, alopecia, diarrhea,
                                    thrombocytopenia, rash, vomiting, decreased appetite, asthenia, and pyrexia. (<a
                                        href="#S6.2">6</a>)</p>
                                <p>
                                    <strong>To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc at 1-800-438-1985
                                        or FDA at 1-800-FDA-1088 or <a
                                            href="https://www.fda.gov/medwatch">www.fda.gov/medwatch</a>.</strong>
                                </p>
                            </div>
                            <div style="narrative">
                                <p>The following clinically significant adverse reactions are described elsewhere in the
                                    labeling:</p>
                                <ul>
                                    <li>Neutropenia <em>[see <a href="#ID_RefS5.1">Warnings and Precautions
                                                (5.1)</a>]</em></li>
                                    <li>ILD/Pneumonitis <em>[see <a href="#ID_RefS5.2">Warnings and Precautions
                                                (5.2)</a>]</em></li>
                                </ul>
                            </div>
                        </div>
                    </text>
                    <section id="0a2d87af-130c-4e47-a33b-8f1bd869be51">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S6.1" />
                        </extension>
                        <title value="6.1 Clinical Studies Experience" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Because clinical trials are conducted under varying conditions, the adverse
                                        reaction rates observed cannot be directly compared to rates in other trials and
                                        may not reflect the rates observed in clinical practice.</p>
                                </div>
                            </div>
                        </text>
                        <section id="b19a4db3-a1bc-4925-85e4-501761575b5a">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-09-13" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_d20d9177-8d5e-4f9a-9ed9-99604e97ccf7" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">
                                            <strong>PALOMA-2: IBRANCE plus
                                                Letrozole</strong>
                                        </p>
                                    </div>
                                </div>
                            </text>
                            <section id="6c0a4e43-f583-4ac2-9f44-7564cbe66208">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2023-09-13" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_efd4058c-cf03-44c0-b548-6910f3cbe691" />
                                </extension>
                                <code>
                                    <coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding>
                                </code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p>
                                                <strong>Patients with estrogen receptor (ER)-positive, HER2-negative
                                                    advanced or metastatic breast cancer for initial endocrine based
                                                    therapy</strong>
                                            </p>
                                            <p>The safety of IBRANCE (125 mg/day) plus letrozole (2.5 mg/day) versus
                                                placebo plus letrozole was evaluated in PALOMA-2. The data described
                                                below reflect exposure to IBRANCE in 444 out of 666 patients with
                                                ER-positive, HER2-negative advanced breast cancer who received at least
                                                1 dose of IBRANCE plus letrozole in PALOMA-2. The median duration of
                                                treatment for IBRANCE plus letrozole was 19.8 months while the median
                                                duration of treatment for placebo plus letrozole arm was 13.8 months.
                                            </p>
                                            <p>Dose reductions due to an adverse reaction of any grade occurred in 36%
                                                of patients receiving IBRANCE plus letrozole. No dose reduction was
                                                allowed for letrozole in PALOMA-2.</p>
                                            <p>Permanent discontinuation associated with an adverse reaction occurred in
                                                43 of 444 (9.7%) patients receiving IBRANCE plus letrozole and in 13 of
                                                222 (5.9%) patients receiving placebo plus letrozole. Adverse reactions
                                                leading to permanent discontinuation for patients receiving IBRANCE plus
                                                letrozole included neutropenia (1.1%) and alanine aminotransferase
                                                increase (0.7%).</p>
                                            <p>The most common adverse reactions (â¥10%) of any grade reported in
                                                patients in the IBRANCE plus letrozole arm by descending frequency were
                                                neutropenia, infections, leukopenia, fatigue, nausea, alopecia,
                                                stomatitis, diarrhea, anemia, rash, asthenia, thrombocytopenia,
                                                vomiting, decreased appetite, dry skin, pyrexia, and dysgeusia.</p>
                                            <p>The most frequently reported Grade â¥3 adverse reactions (â¥5%) in patients
                                                receiving IBRANCE plus letrozole by descending frequency were
                                                neutropenia, leukopenia, infections, and anemia.</p>
                                            <p>Adverse reactions (â¥10%) reported in patients who received IBRANCE plus
                                                letrozole or placebo plus letrozole in PALOMA-2 are listed in Table 4.
                                            </p>
                                            <table width="90%">
                                                <caption>Table 4. Adverse Reactions (â¥10%) in PALOMA-2</caption>
                                                <colgroup span="7">
                                                    <col width="33%" />
                                                    <col width="12%" />
                                                    <col width="10%" />
                                                    <col width="12%" />
                                                    <col width="11%" />
                                                    <col width="11%" />
                                                    <col width="11%" />
                                                </colgroup>
                                                <thead>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="" />
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>IBRANCE plus
                                                                Letrozole</strong>
                                                            <br />
                                                            <strong>(N=444)</strong>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Placebo plus
                                                                Letrozole</strong>
                                                            <br />
                                                            <strong>(N=222)</strong>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-right: solid; border-left: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Adverse Reaction</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                    </tr>
                                                </thead>
                                                <tfoot>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                            colspan="7">Grading according to CTCAE
                                                            4.0.<br />CTCAE=Common Terminology Criteria for Adverse
                                                            Events; N=number of patients; N/A=not applicable;</td>
                                                    </tr>
                                                </tfoot>
                                                <tbody>
                                                    <tr>
                                                        <td colspan="4"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Infections and infestations</p>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: left; border-right: solid; border-top: solid; border-bottom: solid; text-align: left; " />
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Infections<a href="#_RefID0ERKAG" id="ID0EZICK"
                                                                    name="foot-ref-_RefID0ERKAG">
                                                                    <sup>2</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">60<a href="#_RefID0EVKAG"
                                                                    id="ID0ESJCK" name="foot-ref-_RefID0EVKAG">
                                                                    <sup>3</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">6</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">42</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">3</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="4"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Blood and lymphatic system disorders</p>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; " />
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Neutropenia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">80</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">56</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">10</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">6</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Leukopenia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">39</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">24</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Anemia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">24</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">5</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">&lt;1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">9</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Thrombocytopenia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">16</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">&lt;1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="4"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Metabolism and nutrition disorders</p>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; " />
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Decreased appetite</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">15</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">9</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="4"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Nervous system disorders</p>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; " />
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Dysgeusia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">10</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">5</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="4"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Gastrointestinal disorders</p>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; " />
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Stomatitis<a href="#_RefID0EBPAG" id="ID0ELKCK"
                                                                    name="foot-ref-_RefID0EBPAG">
                                                                    <sup>4</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">30</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">14</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Nausea</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">35</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">&lt;1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">26</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Diarrhea</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">26</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">19</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Vomiting</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">16</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">17</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="4"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Skin and subcutaneous tissue disorders</p>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; " />
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Alopecia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">33<a href="#_RefID0EKRAG"
                                                                    id="ID0EELCK" name="foot-ref-_RefID0EKRAG">
                                                                    <sup>5</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">16<a href="#_RefID0ESRAG"
                                                                    id="ID0E4LCK" name="foot-ref-_RefID0ESRAG">
                                                                    <sup>6</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Rash<a href="#_RefID0E2RAG" id="ID0EWMCK"
                                                                    name="foot-ref-_RefID0E2RAG">
                                                                    <sup>7</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">18</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">12</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Dry skin</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">12</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">6</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="4"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>General disorders and administration site conditions</p>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; " />
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Fatigue</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">37</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">28</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Asthenia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">17</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">12</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                            <p> Pyrexia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">12</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">9</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                </tbody>
                                            </table>
                                            <p><sup>
                                                    <a name="_RefID0ERKAG" href="#foot-ref-_RefID0ERKAG">1</a>
                                                </sup>Infections includes all
                                                reported preferred terms (PTs) that are part of the System Organ Class
                                                Infections and infestations.</p>
                                            <p><sup>
                                                    <a name="_RefID0EVKAG" href="#foot-ref-_RefID0EVKAG">2</a>
                                                </sup>Most
                                                common infections (â¥1%) include: nasopharyngitis, upper respiratory
                                                tract infection, urinary tract infection, oral herpes, sinusitis,
                                                rhinitis, bronchitis, influenza, pneumonia, gastroenteritis,
                                                conjunctivitis, herpes zoster, pharyngitis, cellulitis, cystitis, lower
                                                respiratory tract infection, tooth infection, gingivitis, skin
                                                infection, gastroenteritis viral, respiratory tract infection,
                                                respiratory tract infection viral, and folliculitis.</p>
                                            <p><sup>
                                                    <a name="_RefID0EBPAG" href="#foot-ref-_RefID0EBPAG">3</a>
                                                </sup>Stomatitis includes:
                                                aphthous stomatitis, cheilitis, glossitis, glossodynia, mouth
                                                ulceration, mucosal inflammation, oral pain, oral discomfort,
                                                oropharyngeal pain, and stomatitis.</p>
                                            <p><sup>
                                                    <a name="_RefID0EKRAG" href="#foot-ref-_RefID0EKRAG">4</a>
                                                </sup>Grade 1 events â 30%;
                                                Grade 2 events â 3%.</p>
                                            <p><sup>
                                                    <a name="_RefID0ESRAG" href="#foot-ref-_RefID0ESRAG">5</a>
                                                </sup>Grade 1 events â 15%;
                                                Grade 2 events â 1%.</p>
                                            <p><sup>
                                                    <a name="_RefID0E2RAG" href="#foot-ref-_RefID0E2RAG">6</a>
                                                </sup>Rash
                                                includes the following PTs: rash, rash maculo-papular, rash pruritic,
                                                rash erythematous, rash papular, dermatitis, dermatitis acneiform, and
                                                toxic skin eruption.</p>
                                            <p>Additional adverse reactions occurring at an overall incidence of
                                                &lt;10.0% of patients receiving IBRANCE plus letrozole in PALOMA-2
                                                included alanine aminotransferase increased (9.9%), aspartate
                                                aminotransferase increased (9.7%), epistaxis (9.2%), lacrimation
                                                increased (5.6%), dry eye (4.1%), vision blurred (3.6%), and febrile
                                                neutropenia (2.5%).</p>
                                            <table width="75%">
                                                <caption>Table 5. Laboratory Abnormalities in PALOMA-2</caption>
                                                <colgroup span="7">
                                                    <col width="23%" />
                                                    <col width="11%" />
                                                    <col width="10%" />
                                                    <col width="11%" />
                                                    <col width="11%" />
                                                    <col width="10%" />
                                                    <col width="10%" />
                                                </colgroup>
                                                <thead>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="" />
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>IBRANCE plus
                                                                Letrozole</strong>
                                                            <br />
                                                            <strong>(N=444)</strong>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Placebo plus
                                                                Letrozole</strong>
                                                            <br />
                                                            <strong>(N=222)</strong>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-right: solid; border-left: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Laboratory Abnormality</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                    </tr>
                                                </thead>
                                                <tfoot>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                            colspan="7">N=number of patients; WBC=white blood cells.
                                                        </td>
                                                    </tr>
                                                </tfoot>
                                                <tbody>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                            <p>WBC decreased</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">97</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">35</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">25</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Neutrophils decreased</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">95</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">56</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">12</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">20</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Anemia</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">78</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">6</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">42</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Platelets decreased</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">63</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">14</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Aspartate aminotransferase increased</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">52</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">3</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">34</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                            <p>Alanine aminotransferase increased</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">43</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">&lt;1</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">30</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                </tbody>
                                            </table>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                        <section id="7ea11c77-5b65-4c14-a315-719fe4d39ba9">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-09-13" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_b469161e-eaad-455a-822d-2f2b85b7c23b" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">
                                            <strong>PALOMA-3: IBRANCE plus
                                                Fulvestrant</strong>
                                        </p>
                                    </div>
                                </div>
                            </text>
                            <section id="61ef868c-e95a-4487-8e4a-50b116914d09">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2023-09-13" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_6c61fcfa-3484-4385-8d27-31b5bbf41ad4" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p>
                                                <strong>Patients with HR-positive, HER2-negative advanced or metastatic
                                                    breast cancer who have had disease progression on or after prior
                                                    adjuvant or metastatic endocrine therapy</strong>
                                            </p>
                                            <p>The safety of IBRANCE (125 mg/day) plus fulvestrant (500 mg) versus
                                                placebo plus fulvestrant was evaluated in PALOMA-3. The data described
                                                below reflect exposure to IBRANCE in 345 out of 517 patients with
                                                HR-positive, HER2-negative advanced or metastatic breast cancer who
                                                received at least 1 dose of IBRANCE plus fulvestrant in PALOMA-3. The
                                                median duration of treatment for IBRANCE plus fulvestrant was 10.8
                                                months while the median duration of treatment for placebo plus
                                                fulvestrant arm was 4.8 months.</p>
                                            <p>Dose reductions due to an adverse reaction of any grade occurred in 36%
                                                of patients receiving IBRANCE plus fulvestrant. No dose reduction was
                                                allowed for fulvestrant in PALOMA-3.</p>
                                            <p>Permanent discontinuation associated with an adverse reaction occurred in
                                                19 of 345 (6%) patients receiving IBRANCE plus fulvestrant, and in 6 of
                                                172 (3%) patients receiving placebo plus fulvestrant. Adverse reactions
                                                leading to discontinuation for those patients receiving IBRANCE plus
                                                fulvestrant included fatigue (0.6%), infections (0.6%), and
                                                thrombocytopenia (0.6%).</p>
                                            <p>The most common adverse reactions (â¥10%) of any grade reported in
                                                patients in the IBRANCE plus fulvestrant arm by descending frequency
                                                were neutropenia, leukopenia, infections, fatigue, nausea, anemia,
                                                stomatitis, diarrhea, thrombocytopenia, vomiting, alopecia, rash,
                                                decreased appetite, and pyrexia.</p>
                                            <p>The most frequently reported Grade â¥3 adverse reactions (â¥5%) in patients
                                                receiving IBRANCE plus fulvestrant in descending frequency were
                                                neutropenia and leukopenia.</p>
                                            <p>Adverse reactions (â¥10%) reported in patients who received IBRANCE plus
                                                fulvestrant or placebo plus fulvestrant in PALOMA-3 are listed in Table
                                                6.</p>
                                            <table width="85%">
                                                <caption>Table 6. Adverse Reactions (â¥10%) in PALOMA-3</caption>
                                                <colgroup span="7">
                                                    <col width="23%" />
                                                    <col width="19%" />
                                                    <col width="16%" />
                                                    <col width="10%" />
                                                    <col width="11%" />
                                                    <col width="10%" />
                                                    <col width="10%" />
                                                </colgroup>
                                                <thead>
                                                    <tr>
                                                        <td rowspan="3"
                                                            style="text-align: left; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Adverse Reaction</strong>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>IBRANCE plus
                                                                Fulvestrant</strong>
                                                            <br />
                                                            <strong>(N=345)</strong>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Placebo plus
                                                                Fulvestrant</strong>
                                                            <br />
                                                            <strong>(N=172)</strong>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>%</strong>
                                                        </td>
                                                    </tr>
                                                </thead>
                                                <tfoot>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                            colspan="7">Grading according to CTCAE
                                                            4.0.<br />CTCAE=Common Terminology Criteria for Adverse
                                                            Events; N=number of patients; N/A=not applicable.</td>
                                                    </tr>
                                                </tfoot>
                                                <tbody>
                                                    <tr>
                                                        <td colspan="7"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Infections and infestations</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Infections<a href="#_RefID0EK5AG" id="ID0E1DAM"
                                                                    name="foot-ref-_RefID0EK5AG">
                                                                    <sup>2</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">47<a href="#_RefID0EO5AG"
                                                                    id="ID0ETEAM" name="foot-ref-_RefID0EO5AG">
                                                                    <sup>3</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">3</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">31</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">3</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="7"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Blood and lymphatic system disorders</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Neutropenia</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">83</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">55</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">11</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">4</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Leukopenia</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">53</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">30</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">5</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Anemia</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">30</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">4</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">13</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Thrombocytopenia</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">23</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="7"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Metabolism and nutrition disorders</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Decreased appetite</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">16</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">8</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="7"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Gastrointestinal disorders</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Nausea</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">34</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">28</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Stomatitis<a href="#_RefID0EICBG" id="ID0EMFAM"
                                                                    name="foot-ref-_RefID0EICBG">
                                                                    <sup>4</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">28</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">13</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Diarrhea</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">24</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">19</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Vomiting</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">19</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">15</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="7"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Skin and subcutaneous tissue disorders</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Alopecia</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">18<a href="#_RefID0E6DBG"
                                                                    id="ID0EFGAM" name="foot-ref-_RefID0E6DBG">
                                                                    <sup>5</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">6<a href="#_RefID0EHEBG"
                                                                    id="ID0E5GAM" name="foot-ref-_RefID0EHEBG">
                                                                    <sup>6</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">N/A</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p> Rash<a href="#_RefID0EREBG" id="ID0EXHAM"
                                                                    name="foot-ref-_RefID0EREBG">
                                                                    <sup>7</sup>
                                                                </a></p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">17</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">6</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td colspan="7"
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>General disorders and administration site conditions</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; text-align: left; ">
                                                            <p> Fatigue</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">41</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">29</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                            <p> Pyrexia</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">13</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">&lt;1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">5</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                </tbody>
                                            </table>
                                            <p><sup>
                                                    <a name="_RefID0EK5AG" href="#foot-ref-_RefID0EK5AG">1</a>
                                                </sup>Infections includes all
                                                reported preferred terms (PTs) that are part of the System Organ Class
                                                Infections and infestations.</p>
                                            <p><sup>
                                                    <a name="_RefID0EO5AG" href="#foot-ref-_RefID0EO5AG">2</a>
                                                </sup>Most
                                                common infections (â¥1%) include: nasopharyngitis, upper respiratory
                                                infection, urinary tract infection, bronchitis, rhinitis, influenza,
                                                conjunctivitis, sinusitis, pneumonia, cystitis, oral herpes, respiratory
                                                tract infection, gastroenteritis, tooth infection, pharyngitis, eye
                                                infection, herpes simplex, and paronychia.</p>
                                            <p><sup>
                                                    <a name="_RefID0EICBG" href="#foot-ref-_RefID0EICBG">3</a>
                                                </sup>Stomatitis includes:
                                                aphthous stomatitis, cheilitis, glossitis, glossodynia, mouth
                                                ulceration, mucosal inflammation, oral pain, oropharyngeal discomfort,
                                                oropharyngeal pain, stomatitis.</p>
                                            <p><sup>
                                                    <a name="_RefID0E6DBG" href="#foot-ref-_RefID0E6DBG">4</a>
                                                </sup>Grade 1 events â 17%;
                                                Grade 2 events â 1%.</p>
                                            <p><sup>
                                                    <a name="_RefID0EHEBG" href="#foot-ref-_RefID0EHEBG">5</a>
                                                </sup>Grade 1 events â 6%.
                                            </p>
                                            <p><sup>
                                                    <a name="_RefID0EREBG" href="#foot-ref-_RefID0EREBG">6</a>
                                                </sup>Rash
                                                includes: rash, rash maculo-papular, rash pruritic, rash erythematous,
                                                rash papular, dermatitis, dermatitis acneiform, toxic skin eruption.</p>
                                            <p>Additional adverse reactions occurring at an overall incidence of
                                                &lt;10.0% of patients receiving IBRANCE plus fulvestrant in PALOMA-3
                                                included asthenia (7.5%), aspartate aminotransferase increased (7.5%),
                                                dysgeusia (6.7%), epistaxis (6.7%), lacrimation increased (6.4%), dry
                                                skin (6.1%), alanine aminotransferase increased (5.8%), vision blurred
                                                (5.8%), dry eye (3.8%), and febrile neutropenia (0.9%).</p>
                                            <table width="80%">
                                                <caption>Table 7. Laboratory Abnormalities in PALOMA-3</caption>
                                                <colgroup span="7">
                                                    <col width="21%" />
                                                    <col width="17%" />
                                                    <col width="14%" />
                                                    <col width="10%" />
                                                    <col width="10%" />
                                                    <col width="10%" />
                                                    <col width="9%" />
                                                </colgroup>
                                                <thead>
                                                    <tr>
                                                        <td rowspan="2"
                                                            style="text-align: left; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Laboratory Abnormality</strong>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>IBRANCE plus
                                                                Fulvestrant</strong>
                                                            <br />
                                                            <strong>(N=345)</strong>
                                                        </td>
                                                        <td colspan="3"
                                                            style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Placebo plus
                                                                Fulvestrant</strong>
                                                            <br />
                                                            <strong>(N=172)</strong>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>All Grades</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 3</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                            align="">
                                                            <strong>Grade 4</strong>
                                                            <br />
                                                            <strong>%</strong>
                                                        </td>
                                                    </tr>
                                                </thead>
                                                <tfoot>
                                                    <tr>
                                                        <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                            colspan="7">N=number of patients; WBC=white blood cells.
                                                        </td>
                                                    </tr>
                                                </tfoot>
                                                <tbody>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                            <p>WBC decreased</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">99</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">45</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">26</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Neutrophils decreased</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">96</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">56</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">11</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">14</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Anemia</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">78</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">3</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">40</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Platelets decreased</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">62</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">1</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">10</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                            <p>Aspartate aminotransferase increased </p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">43</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">4</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">48</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">4</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                    <tr>
                                                        <td
                                                            style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                            <p>Alanine aminotransferase increased</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">36</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">2</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">34</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                        <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                            align="center">
                                                            <p style="text-align: center; ">0</p>
                                                        </td>
                                                    </tr>
                                                </tbody>
                                            </table>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                    </section>
                    <section id="8ff1743c-7716-4dfd-9c7a-f8aeb81d29db">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S6.2" />
                        </extension>
                        <title value="6.2 Postmarketing Experience" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The following adverse reactions have been identified during post-approval use of
                                        IBRANCE. Because these reactions are reported voluntarily from a population of
                                        uncertain size, it is not always possible to reliably estimate their frequency
                                        or establish a causal relationship to drug exposure.</p>
                                    <p><em>Respiratory Disorders</em>: Interstitial lung disease (ILD)/non-infectious
                                        pneumonitis</p>
                                    <p><em>Skin and Subcutaneous Tissue Disorders:</em> Palmar-plantar
                                        erythrodysesthesia syndrome (PPES)</p>
                                </div>
                            </div>
                        </text>
                        <section id="dde5a6df-f7d5-41a1-959a-58d8fc82df52">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_abf81276-0bd9-4811-87b4-a175f89bbe36" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">
                                            <strong>Male patients with HR-positive,
                                                HER2-negative advanced or metastatic breast cancer</strong>
                                        </p>
                                        <p>Based on limited data from postmarketing reports and electronic health
                                            records, the safety profile for men treated with IBRANCE is consistent with
                                            the safety profile in women treated with IBRANCE.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                </section>
                <section id="80ba5b55-6f05-4ac8-81a7-630988341a5d">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S7" />
                    </extension>
                    <title value="7 DRUG INTERACTIONS" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="34073-7"/>
							<display value="DRUG INTERACTIONS SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <ul>
                                    <li>CYP3A Inhibitors: Avoid concurrent use of IBRANCE with strong CYP3A inhibitors.
                                        If the strong inhibitor cannot be avoided, reduce the IBRANCE dose. (<a
                                            href="#ID_RefS2.2">2.2</a>, <a href="#ID_RefS7.1">7.1</a>) </li>
                                    <li>CYP3A Inducers: Avoid concurrent use of IBRANCE with strong CYP3A inducers. (<a
                                            href="#S7.2">7.2</a>)</li>
                                    <li>CYP3A Substrates: The dose of sensitive CYP3A4 substrates with narrow
                                        therapeutic indices may need to be reduced when given concurrently with IBRANCE.
                                        (<a href="#ID_RefS7.3">7.3</a>)</li>
                                </ul>
                            </div>
                            <div style="narrative">
                                <p>Palbociclib is primarily metabolized by CYP3A and sulfotransferase (SULT) enzyme
                                    SULT2A1. In vivo, palbociclib is a time-dependent inhibitor of CYP3A.</p>
                            </div>
                        </div>
                    </text>
                    <section id="467df45f-cc69-4bda-a347-381ded5e31da">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S7.1" />
                        </extension>
                        <title value="7.1 Agents That May Increase Palbociclib Plasma Concentrations" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <section id="62515dd1-5290-44e1-af77-01aaae31bad3">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_4acec7b7-c8f0-40d0-8733-3d23640ecdbe" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Effect of CYP3A Inhibitors</strong>
                                        </p>
                                        <p>Coadministration of a strong CYP3A inhibitor (itraconazole) increased the
                                            plasma exposure of palbociclib in healthy subjects by 87%. Avoid concomitant
                                            use of strong CYP3A inhibitors (e.g., clarithromycin, indinavir,
                                            itraconazole, ketoconazole, lopinavir/ritonavir, nefazodone, nelfinavir,
                                            posaconazole, ritonavir, saquinavir, telaprevir, telithromycin, and
                                            voriconazole). Avoid grapefruit or grapefruit juice during IBRANCE
                                            treatment. If coadministration of IBRANCE with a strong CYP3A inhibitor
                                            cannot be avoided, reduce the dose of IBRANCE <em>[see <a
                                                    href="#ID_RefS2.2">Dosage and Administration (2.2)</a> and <a
                                                    href="#ID_RefS12.3">Clinical Pharmacology (12.3)</a>]</em>.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="c1a668f3-bcb1-42db-99dd-4e7044442fd3">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S7.2" />
                        </extension>
                        <title value="7.2 Agents That May Decrease Palbociclib Plasma Concentrations" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <section id="2d061397-9dd2-44d5-bba0-d8a7129e69c7">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_d47a285c-2857-43b9-9a10-7e85f60647b7" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Effect of CYP3A Inducers</strong>
                                        </p>
                                        <p>Coadministration of a strong CYP3A inducer (rifampin) decreased the plasma
                                            exposure of palbociclib in healthy subjects by 85%. Avoid concomitant use of
                                            strong CYP3A inducers (e.g., phenytoin, rifampin, carbamazepine,
                                            enzalutamide, and St John's Wort) <em>[see <a href="#ID_RefS12.3">Clinical
                                                    Pharmacology (12.3)</a>]</em>.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="ff17e88b-6dc3-4a65-a7c6-a168dd4be175">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S7.3" />
                        </extension>
                        <title value="7.3 Drugs That May Have Their Plasma Concentrations Altered by Palbociclib" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Coadministration of midazolam with multiple doses of IBRANCE increased the
                                        midazolam plasma exposure by 61%, in healthy subjects, compared to
                                        administration of midazolam alone. The dose of the sensitive CYP3A substrate
                                        with a narrow therapeutic index (e.g., alfentanil, cyclosporine,
                                        dihydroergotamine, ergotamine, everolimus, fentanyl, pimozide, quinidine,
                                        sirolimus, and tacrolimus) may need to be reduced, as IBRANCE may increase its
                                        exposure <em>[see <a href="#ID_RefS12.3">Clinical Pharmacology (12.3)</a>]</em>.
                                    </p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="30e4e134-5497-43b6-ae32-92558b6b22dc">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S8" />
                    </extension>
                    <title value="8 USE IN SPECIFIC POPULATIONS" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="43684-0"/>
							<display value="USE IN SPECIFIC POPULATIONS SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <ul>
                                    <li>Lactation: Advise not to breastfeed. (<a href="#ID_RefS8.2">8.2</a>)</li>
                                </ul>
                            </div>
                        </div>
                    </text>
                    <section id="ee09c35f-ae11-4661-bb7b-88cfa4f5f312">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.1" />
                        </extension>
                        <title value="8.1 Pregnancy" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42228-7"/>
								<display value="PREGNANCY SECTION"/>
							</coding></code>
                        <section id="5f9422c2-0428-414a-81b1-900e3d4ac8b2">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_06a69bd8-7a6f-42ec-a7f7-8dbf8d035066" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Risk Summary</strong>
                                        </p>
                                        <p>Based on findings from animal studies and its mechanism of action, IBRANCE
                                            can cause fetal harm when administered to a pregnant woman <em>[see <a
                                                    href="#ID_RefS12.1">Clinical Pharmacology (12.1)</a>]</em>. There
                                            are no available data in pregnant women to inform the drug-associated risk.
                                            In animal reproduction studies, administration of palbociclib to pregnant
                                            rats and rabbits during organogenesis resulted in embryo-fetal toxicity at
                                            maternal exposures that were â¥4 times the human clinical exposure based on
                                            AUC <em>[see </em><strong>Error! Hyperlink reference not
                                                valid.</strong><em>]</em>. Advise pregnant women of the potential risk
                                            to a fetus.</p>
                                        <p>The estimated background risk of major birth defects and miscarriage for the
                                            indicated population is unknown. In the U.S. general population, the
                                            estimated background risk of major birth defects and miscarriage in
                                            clinically recognized pregnancies is 2%â4% and 15%â20%, respectively.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="fda29021-94b6-49e6-85dc-6c44bab15fc7">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="data" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Data</strong>
                                        </p>
                                    </div>
                                </div>
                            </text>
                            <section id="201f84bf-75ab-48b0-8b9a-2905120d9a7c">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_c6c9776f-4031-40ab-b2b9-c04a52a24246" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p style="text-decoration: underline; ">Animal Data</p>
                                            <p>In a fertility and early embryonic development study in female rats,
                                                palbociclib was administered orally for 15 days before mating through to
                                                Day 7 of pregnancy, which did not cause embryo toxicity at doses up to
                                                300 mg/kg/day with maternal systemic exposures approximately 4 times the
                                                human exposure (AUC) at the recommended dose.</p>
                                            <p>In embryo-fetal development studies in rats and rabbits, pregnant animals
                                                received oral doses of palbociclib up to 300 mg/kg/day and 20 mg/kg/day,
                                                respectively, during the period of organogenesis. The maternally toxic
                                                dose of 300 mg/kg/day was fetotoxic in rats, resulting in reduced fetal
                                                body weights. At doses â¥100 mg/kg/day in rats, there was an increased
                                                incidence of a skeletal variation (increased incidence of a rib present
                                                at the seventh cervical vertebra). At the maternally toxic dose of 20
                                                mg/kg/day in rabbits, there was an increased incidence of skeletal
                                                variations, including small phalanges in the forelimb. At 300 mg/kg/day
                                                in rats and 20 mg/kg/day in rabbits, the maternal systemic exposures
                                                were approximately 4 and 9 times the human exposure (AUC) at the
                                                recommended dose, respectively.</p>
                                            <p>CDK4/6 double knockout mice have been reported to die in late stages of
                                                fetal development (gestation Day 14.5 until birth) due to severe anemia.
                                                However, knockout mouse data may not be predictive of effects in humans
                                                due to differences in degree of target inhibition.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                    </section>
                    <section id="560df3fe-329b-4817-87da-6727ebfbb101">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.2" />
                        </extension>
                        <title value="8.2 Lactation" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="77290-5"/>
								<display value="LACTATION SECTION"/>
							</coding></code>
                        <section id="2161f068-488f-4067-9ee9-5f77268aa131">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_2168b375-ad50-4d80-841a-b9c66b0bbda7" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Risk Summary</strong>
                                        </p>
                                        <p>There is no information regarding the presence of palbociclib in human milk,
                                            its effects on milk production, or the breastfed infant. Because of the
                                            potential for serious adverse reactions in breastfed infants from IBRANCE,
                                            advise a lactating woman not to breastfeed during treatment with IBRANCE and
                                            for 3 weeks after the last dose.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="206f2e51-f440-47f8-aa57-25a6aea8e761">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.3" />
                        </extension>
                        <title value="8.3 Females and Males of Reproductive Potential" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="77291-3"/>
								<display value="FEMALES &amp; MALES OF REPRODUCTIVE POTENTIAL SECTION"/>
							</coding></code>
                        <section id="7214e588-c105-4832-9887-95dc223c499d">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_13c0e7c5-cec6-42fc-bf1f-1b7e5467954d" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Pregnancy Testing</strong>
                                        </p>
                                        <p>Based on animal studies, IBRANCE can cause fetal harm when administered to a
                                            pregnant woman <em>[see <a href="#ID_RefS8.1">Use in Specific Populations
                                                    (8.1)]</a>. </em>Females of reproductive potential should have a
                                            pregnancy test prior to starting treatment with IBRANCE.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="8769473a-c0f2-45a1-8070-b9d77ca8744b">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_cf0fe8a0-a761-4c54-804c-046b3560c0e6" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Contraception</strong>
                                        </p>
                                    </div>
                                </div>
                            </text>
                            <section id="d8806170-92a6-4f54-ad0d-a00036483ce4">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_b8bf300f-da1c-4955-b9f8-132a01d91c3c" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p style="text-decoration: underline; ">Females</p>
                                            <p>IBRANCE can cause fetal harm when administered to a pregnant woman
                                                <em>[see <a href="#ID_RefS8.1">Use in Specific Populations
                                                        (8.1)</a>]</em>. Advise females of reproductive potential to use
                                                effective contraception during treatment with IBRANCE and for at least 3
                                                weeks after the last dose.
                                            </p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="6788eb62-563b-448d-9c13-9ad97a6738ba">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_5426da22-7376-42ad-857b-054e1e60088d" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p style="text-decoration: underline; ">Males</p>
                                            <p>Because of the potential for genotoxicity, advise male patients with
                                                female partners of reproductive potential to use effective contraception
                                                during treatment with IBRANCE and for 3 months after the last dose
                                                <em>[see <a href="#ID_RefS13.1">Nonclinical Toxicology (13.1)</a>]</em>.
                                            </p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                        <section id="31204452-26e7-404d-81e4-09f7f3e7a47a">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_f6755e3a-700f-4ee3-834b-c4aed1b205ec" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Infertility</strong>
                                        </p>
                                    </div>
                                </div>
                            </text>
                            <section id="dae0da06-a9dc-4e80-9df2-a095a86ced08">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_9616fe8b-dd4b-401b-8384-4a7ab2778efd" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p style="text-decoration: underline; ">Males</p>
                                            <p>Based on animal studies, IBRANCE may impair fertility in males of
                                                reproductive potential <em>[see <a href="#ID_RefS13.1">Nonclinical
                                                        Toxicology (13.1)</a>]</em>.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                    </section>
                    <section id="eb6f21a3-6662-4d0d-a39a-c6d4835af455">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.4" />
                        </extension>
                        <title value="8.4 Pediatric Use" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="34081-0"/>
								<display value="PEDIATRIC USE SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The safety and efficacy of IBRANCE in pediatric patients have not been studied.
                                    </p>
                                    <p>Altered glucose metabolism (glycosuria, hyperglycemia, decreased insulin)
                                        associated with changes in the pancreas (islet cell vacuolation), eye
                                        (cataracts, lens degeneration), kidney (tubule vacuolation, chronic progressive
                                        nephropathy) and adipose tissue (atrophy) were identified in a 27 week
                                        repeat-dose toxicology study in rats that were immature at the beginning of the
                                        studies and were most prevalent in males at oral palbociclib doses â¥30 mg/kg/day
                                        (approximately 11 times the adult human exposure [AUC] at the recommended dose).
                                        Some of these findings (glycosuria/hyperglycemia, pancreatic islet cell
                                        vacuolation, and kidney tubule vacuolation) were present with lower incidence
                                        and severity in a 15 week repeat-dose toxicology study in immature rats. Altered
                                        glucose metabolism or associated changes in the pancreas, eye, kidney and
                                        adipose tissue were not identified in a 27-week repeat-dose toxicology study in
                                        rats that were mature at the beginning of the study and in dogs in repeat-dose
                                        toxicology studies up to 39 weeks duration.</p>
                                    <p>Toxicities in teeth independent of altered glucose metabolism were observed in
                                        rats. Administration of 100 mg/kg palbociclib for 27 weeks (approximately 15
                                        times the adult human exposure [AUC] at the recommended dose) resulted in
                                        abnormalities in growing incisor teeth (discolored, ameloblast
                                        degeneration/necrosis, mononuclear cell infiltrate). Other toxicities of
                                        potential concern to pediatric patients have not been evaluated in juvenile
                                        animals.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="5040a367-697e-43df-bab7-11bbefd3546f">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.5" />
                        </extension>
                        <title value="8.5 Geriatric Use" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="34082-8"/>
								<display value="GERIATRIC USE SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Of 444 patients who received IBRANCE in PALOMA-2, 181 patients (41%) were â¥65
                                        years of age and 48 patients (11%) were â¥75 years of age. Of 347 patients who
                                        received IBRANCE in PALOMA-3, 86 patients (25%) were â¥65 years of age and 27
                                        patients (8%) were â¥75 years of age. No overall differences in safety or
                                        effectiveness of IBRANCE were observed between these patients and younger
                                        patients.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="627a5424-4358-4f07-9854-5966e895b741">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.6" />
                        </extension>
                        <title value="8.6 Hepatic Impairment" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>No dose adjustment is required in patients with mild or moderate hepatic
                                        impairment (Child-Pugh classes A and B). For patients with severe hepatic
                                        impairment (Child-Pugh class C), the recommended dose of IBRANCE is 75 mg once
                                        daily for 21 consecutive days followed by 7 days off treatment to comprise a
                                        complete cycle of 28 days <em>[see <a href="#ID_RefS2.2">Dosage and
                                                Administration (2.2)</a>]</em>. Based on a pharmacokinetic trial in
                                        subjects with varying degrees of hepatic function, the palbociclib unbound
                                        exposure (unbound AUC<sub>INF</sub>) decreased by 17% in subjects with mild
                                        hepatic impairment (Child-Pugh class A), and increased by 34% and 77% in
                                        subjects with moderate (Child-Pugh class B) and severe (Child-Pugh class C)
                                        hepatic impairment, respectively, relative to subjects with normal hepatic
                                        function. Peak palbociclib unbound exposure (unbound C<sub>max</sub>) increased
                                        by 7%, 38% and 72% for mild, moderate and severe hepatic impairment,
                                        respectively, relative to subjects with normal hepatic function <em>[see <a
                                                href="#ID_RefS12.3">Clinical Pharmacology (12.3)</a>]</em>. </p>
                                    <p>Review the Full Prescribing Information for the aromatase inhibitor or
                                        fulvestrant for dose modifications related to hepatic impairment.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="88abdb31-38bb-4a5d-a2a2-baa086d359d8">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.7" />
                        </extension>
                        <title value="8.7 Renal Impairment" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>No dose adjustment is required in patients with mild, moderate, or severe renal
                                        impairment (CrCl &gt;15 mL/min). Based on a pharmacokinetic trial in subjects
                                        with varying degrees of renal function, the total palbociclib exposure
                                        (AUC<sub>INF</sub>) increased by 39%, 42%, and 31% with mild (60 mL/min â¤ CrCl
                                        &lt;90 mL/min), moderate (30 mL/min â¤ CrCl &lt;60 mL/min), and severe (CrCl
                                        &lt;30 mL/min) renal impairment, respectively, relative to subjects with normal
                                        renal function. Peak palbociclib exposure (C<sub>max</sub>) increased by 17%,
                                        12%, and 15% for mild, moderate, and severe renal impairment, respectively,
                                        relative to subjects with normal renal function. The pharmacokinetics of
                                        palbociclib have not been studied in patients requiring hemodialysis <em>[see <a
                                                href="#ID_RefS12.3">Clinical Pharmacology (12.3)</a>]</em>.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="309b85d0-8834-4f8f-a1d0-9f94ed229fea">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S10" />
                    </extension>
                    <title value="10 OVERDOSAGE" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="34088-5"/>
							<display value="OVERDOSAGE SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>There is no known antidote for IBRANCE. The treatment of overdose of IBRANCE should
                                    consist of general supportive measures.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="c3c232cd-fd32-4ddb-a914-f2517a7bb300">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S11" />
                    </extension>
                    <title value="11 DESCRIPTION" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="34089-3"/>
							<display value="DESCRIPTION SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>IBRANCE capsules for oral administration contain 125 mg, 100 mg, or 75 mg of
                                    palbociclib, a kinase inhibitor. The molecular formula for palbociclib is
                                    C<sub>24</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>. The molecular weight is
                                    447.54 daltons. The chemical name is
                                    6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-<em>d</em>]pyrimidin-7(8<em>H</em>)-one,
                                    and its structural formula is:</p>
                                <img src="#ibrance-01" alt="Chemical Structure" />
                                <p>Palbociclib is a yellow to orange powder with pKa of 7.4 (the secondary piperazine
                                    nitrogen) and 3.9 (the pyridine nitrogen). At or below pH 4, palbociclib behaves as
                                    a high-solubility compound. Above pH 4, the solubility of the drug substance reduces
                                    significantly.</p>
                                <p><em>Inactive ingredients:</em> Microcrystalline cellulose, lactose monohydrate,
                                    sodium starch glycolate, colloidal silicon dioxide, magnesium stearate, and hard
                                    gelatin capsule shells. The light orange, light orange/caramel, and caramel opaque
                                    capsule shells contain gelatin, red iron oxide, yellow iron oxide, and titanium
                                    dioxide; the printing ink contains shellac, titanium dioxide, ammonium hydroxide,
                                    propylene glycol, and simethicone.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="3f22add8-2f87-490a-894c-dae72f7769d8">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S12" />
                    </extension>
                    <title value="12 CLINICAL PHARMACOLOGY" />
                    <code>
                        <coding>
							<system value="http://loinc.org"/>
							<code value="34090-1"/>
							<display value="CLINICAL PHARMACOLOGY SECTION"/>
						</coding>
                    </code>
                    <section id="d20291d2-96c9-4e20-91df-fd4812dab1f7">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S12.1" />
                        </extension>
                        <title value="12.1 Mechanism of Action" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="43679-0"/>
								<display value="MECHANISM OF ACTION SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Palbociclib is an inhibitor of cyclin-dependent kinases (CDK) 4 and 6. Cyclin D1
                                        and CDK4/6 are downstream of signaling pathways which lead to cellular
                                        proliferation. In vitro, palbociclib reduced cellular proliferation of estrogen
                                        receptor (ER)-positive breast cancer cell lines by blocking progression of the
                                        cell from G1 into S phase of the cell cycle. Treatment of breast cancer cell
                                        lines with the combination of palbociclib and antiestrogens leads to decreased
                                        retinoblastoma (Rb) protein phosphorylation resulting in reduced E2F expression
                                        and signaling, and increased growth arrest compared to treatment with each drug
                                        alone. In vitro treatment of ER-positive breast cancer cell lines with the
                                        combination of palbociclib and antiestrogens led to increased cell senescence
                                        compared to each drug alone, which was sustained for up to 6 days following
                                        palbociclib removal and was greater if antiestrogen treatment was continued. In
                                        vivo studies using a patient-derived ER-positive breast cancer xenograft model
                                        demonstrated that the combination of palbociclib and letrozole increased the
                                        inhibition of Rb phosphorylation, downstream signaling, and tumor growth
                                        compared to each drug alone.</p>
                                    <p>Human bone marrow mononuclear cells treated with palbociclib in the presence or
                                        absence of an anti-estrogen in vitro did not become senescent and resumed
                                        proliferation following palbociclib withdrawal. </p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="caac6a35-b69b-4ae9-a7a4-387b3c2c985c">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S12.2" />
                        </extension>
                        <title value="12.2 Pharmacodynamics" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="43681-6"/>
								<display value="PHARMACODYNAMICS SECTION"/>
							</coding></code>
                        <section id="e4781ae0-392c-4e39-8279-1dba4f42e322">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_64d039b9-ce29-4d8f-a9ac-456d11306b40" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Cardiac Electrophysiology</strong>
                                        </p>
                                        <p>The effect of palbociclib on the QT interval corrected for heart rate (QTc)
                                            was evaluated using time-matched electrocardiograms (ECGs) evaluating the
                                            change from baseline and corresponding pharmacokinetic data in 77 patients
                                            with breast cancer. Palbociclib had no large effect on QTc (i.e., &gt;20 ms)
                                            at 125 mg once daily for 21 consecutive days followed by 7 days off
                                            treatment to comprise a complete cycle of 28 days.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="2efd2763-57b8-4f1f-8c2a-69b4f529b7a7">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S12.3" />
                        </extension>
                        <title value="12.3 Pharmacokinetics" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="43682-4"/>
								<display value="PHARMACOKINETICS SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The pharmacokinetics (PK) of palbociclib were characterized in patients with
                                        solid tumors including advanced breast cancer and in healthy subjects.</p>
                                </div>
                            </div>
                        </text>
                        <section id="8ed8efc3-08db-454d-a11e-13fd194401d6">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_209dc345-a3ca-4466-9650-5c11a9a562d5" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Absorption</strong>
                                        </p>
                                        <p>The mean maximum observed concentration (C<sub>max</sub>) of palbociclib is
                                            generally observed between 6 to 12 hours (time to reach maximum
                                            concentration, T<sub>max</sub>) following oral administration. The mean
                                            absolute bioavailability of IBRANCE after an oral 125 mg dose is 46%. In the
                                            dosing range of 25 mg to 225 mg, the AUC and C<sub>max</sub> increased
                                            proportionally with dose in general. Steady state was achieved within 8 days
                                            following repeated once daily dosing. With repeated once daily
                                            administration, palbociclib accumulated with a median accumulation ratio of
                                            2.4 (range 1.5 to 4.2).</p>
                                    </div>
                                </div>
                            </text>
                            <section id="8a57b379-acb6-455f-9f12-aecaec851f24">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_461235ab-ed6d-4f81-bb7d-bf506e23dee1" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><span style="text-decoration: underline; ">Food effect</span>:
                                                Palbociclib absorption and exposure were very low in approximately 13%
                                                of the population under the fasted condition. Food intake increased the
                                                palbociclib exposure in this small subset of the population, but did not
                                                alter palbociclib exposure in the rest of the population to a clinically
                                                relevant extent. Therefore, food intake reduced the intersubject
                                                variability of palbociclib exposure, which supports administration of
                                                IBRANCE with food. Compared to IBRANCE given under overnight fasted
                                                conditions, the population average area under the concentration-time
                                                curve from zero to infinity (AUC<sub>INF</sub>) and C<sub>max</sub> of
                                                palbociclib increased by 21% and 38%, respectively, when given with
                                                high-fat, high-calorie food (approximately 800 to 1000 calories with
                                                150, 250, and 500 to 600 calories from protein, carbohydrate, and fat,
                                                respectively), by 12% and 27%, respectively, when given with low-fat,
                                                low-calorie food (approximately 400 to 500 calories with 120, 250, and
                                                28 to 35 calories from protein, carbohydrate, and fat, respectively),
                                                and by 13% and 24%, respectively, when moderate-fat, standard calorie
                                                food (approximately 500 to 700 calories with 75 to 105, 250 to 350 and
                                                175 to 245 calories from protein, carbohydrate, and fat, respectively)
                                                was given 1 hour before and 2 hours after IBRANCE dosing.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                        <section id="39ff054a-2533-4d2e-868b-ff94bf33136c">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_c1127bab-bbc2-484b-a04c-3c8213100f84" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Distribution</strong>
                                        </p>
                                        <p>Binding of palbociclib to human plasma proteins in vitro was approximately
                                            85%, with no concentration dependence over the concentration range of 500
                                            ng/mL to 5000 ng/mL. The mean fraction unbound (f<sub>u</sub>) of
                                            palbociclib in human plasma in vivo increased incrementally with worsening
                                            hepatic function. There was no obvious trend in the mean palbociclib
                                            f<sub>u</sub> in human plasma in vivo with worsening renal function. The
                                            geometric mean apparent volume of distribution (V<sub>z</sub>/F) was 2583 L
                                            with a coefficient of variation (CV) of 26%.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="01b39606-1ff4-4f15-a8d3-f11b6536d21d">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_1914d8fc-3718-41ff-addd-896a2e9af177" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Metabolism</strong>
                                        </p>
                                        <p>In vitro and in vivo studies indicated that palbociclib undergoes hepatic
                                            metabolism in humans. Following oral administration of a single 125 mg dose
                                            of [<sup>14</sup>C]palbociclib to humans, the primary metabolic pathways for
                                            palbociclib involved oxidation and sulfonation, with acylation and
                                            glucuronidation contributing as minor pathways. Palbociclib was the major
                                            circulating drug-derived entity in plasma (23%). The major circulating
                                            metabolite was a glucuronide conjugate of palbociclib, although it only
                                            represented 1.5% of the administered dose in the excreta. Palbociclib was
                                            extensively metabolized with unchanged drug accounting for 2.3% and 6.9% of
                                            radioactivity in feces and urine, respectively. In feces, the sulfamic acid
                                            conjugate of palbociclib was the major drug-related component, accounting
                                            for 26% of the administered dose. In vitro studies with human hepatocytes,
                                            liver cytosolic and S9 fractions, and recombinant SULT enzymes indicated
                                            that CYP3A and SULT2A1 are mainly involved in the metabolism of palbociclib.
                                        </p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="eaa1c656-3835-46a6-871d-0d4d2dabf29f">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_a7a11be4-9624-4acc-b4ba-f156a7b9c03b" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Elimination</strong>
                                        </p>
                                        <p>The geometric mean apparent oral clearance (CL/F) of palbociclib was 63.1
                                            L/hr (29% CV), and the mean (Â± standard deviation) plasma elimination
                                            half-life was 29 (Â±5) hours in patients with advanced breast cancer. In 6
                                            healthy male subjects given a single oral dose of
                                            [<sup>14</sup>C]palbociclib, a median of 91.6% of the total administered
                                            radioactive dose was recovered in 15 days; feces (74.1% of dose) was the
                                            major route of excretion, with 17.5% of the dose recovered in urine. The
                                            majority of the material was excreted as metabolites.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="f4ff6b82-4f8a-423b-b081-4d6e3c771aa8">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_50b4b27b-d9f0-4512-a09c-04ae58472bee" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Age, Gender, and Body Weight</strong>
                                        </p>
                                        <p>Based on a population pharmacokinetic analysis in 183 patients with cancer
                                            (50 male and 133 female patients, age range from 22 to 89 years, and body
                                            weight range from 37.9 to 123 kg), gender had no effect on the exposure of
                                            palbociclib, and age and body weight had no clinically important effect on
                                            the exposure of palbociclib.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="20c1170b-b3f4-45dc-a742-e04f79180b06">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_c517fc4c-9c43-4f9d-bbad-42ed3980353b" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Pediatric Population</strong>
                                        </p>
                                        <p>Pharmacokinetics of IBRANCE have not been evaluated in patients &lt;18 years
                                            of age.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="46a4b5c5-3ecf-4a4d-95c2-deef5438d5b5">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_c9a13c98-4536-4df3-8d89-6c4106837399" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Hepatic Impairment</strong>
                                        </p>
                                        <p>Data from a pharmacokinetic trial in subjects with varying degrees of hepatic
                                            impairment indicate that palbociclib unbound AUC<sub>INF</sub> decreased 17%
                                            in subjects with mild hepatic impairment (Child-Pugh class A), and increased
                                            by 34% and 77% in subjects with moderate (Child-Pugh class B) and severe
                                            (Child-Pugh class C) hepatic impairment, respectively, relative to subjects
                                            with normal hepatic function. Palbociclib unbound C<sub>max</sub> increased
                                            by 7%, 38% and 72% for mild, moderate and severe hepatic impairment,
                                            respectively, relative to subjects with normal hepatic function. In
                                            addition, based on a population pharmacokinetic analysis that included 183
                                            patients, where 40 patients had mild hepatic impairment based on National
                                            Cancer Institute (NCI) classification (total bilirubin â¤ ULN and AST &gt;
                                            ULN, or total bilirubin &gt;1.0 to 1.5 Ã ULN and any AST), mild hepatic
                                            impairment had no effect on the exposure of palbociclib, further supporting
                                            the findings from the dedicated hepatic impairment study.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="bc29fe76-15b8-4f73-8e44-6c5d484c8770">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2022-12-16" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_d17364fa-90a8-496d-b56e-701ac3d16042" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Renal Impairment</strong>
                                        </p>
                                        <p>Data from a pharmacokinetic trial in subjects with varying degrees of renal
                                            impairment indicate that palbociclib AUC<sub>INF</sub> increased by 39%,
                                            42%, and 31% with mild (60 mL/min â¤ CrCl &lt; 90 mL/min), moderate (30
                                            mL/min â¤ CrCl &lt;60 mL/min), and severe (CrCl &lt;30 mL/min) renal
                                            impairment, respectively, relative to subjects with normal renal function.
                                            Peak palbociclib exposure (C<sub>max</sub>) increased by 17%, 12%, and 15%
                                            for mild, moderate, and severe renal impairment, respectively, relative to
                                            subjects with normal renal function. In addition, based on a population
                                            pharmacokinetic analysis that included 183 patients where 73 patients had
                                            mild renal impairment and 29 patients had moderate renal impairment, mild
                                            and moderate renal impairment had no effect on the exposure of palbociclib.
                                            The pharmacokinetics of palbociclib have not been studied in patients
                                            requiring hemodialysis.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="0d47fca8-7f58-49a4-8398-bcfce834d1e2">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-09-13" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_c55398f6-62a6-4e9e-9c76-e3c66c2d4fa5" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Drug Interactions</strong>
                                        </p>
                                        <p>In vitro data indicate that CYP3A and SULT enzyme SULT2A1 are mainly involved
                                            in the metabolism of palbociclib. Palbociclib is a weak time-dependent
                                            inhibitor of CYP3A following daily 125 mg dosing to steady state in humans.
                                            In vitro, palbociclib is not an inhibitor of CYP1A2, 2A6, 2B6, 2C8, 2C9,
                                            2C19, and 2D6, and is not an inducer of CYP1A2, 2B6, 2C8, and 3A4 at
                                            clinically relevant concentrations.</p>
                                    </div>
                                </div>
                            </text>
                            <section id="e8322b7f-a4f9-4daf-aba4-e4f5e5ef2300">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_49529cb2-58c5-47d7-9e6a-4b6f43090191" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>CYP3A Inhibitors:</em> Data from a drug interaction trial in healthy
                                                subjects (N=12) indicate that coadministration of multiple 200 mg daily
                                                doses of itraconazole with a single 125 mg IBRANCE dose increased
                                                palbociclib AUC<sub>INF</sub> and the C<sub>max</sub> by approximately
                                                87% and 34%, respectively, relative to a single 125 mg IBRANCE dose
                                                given alone <em>[see <a href="#S7.1">Drug Interactions (7.1</a>)]</em>.
                                            </p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="3a23b749-4d85-43c6-a895-ee146e7f0015">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_fcaee425-a0ce-49f2-971b-9c93fdfb064f" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>CYP3A Inducers:</em> Data from a drug interaction trial in healthy
                                                subjects (N=15) indicate that coadministration of multiple 600 mg daily
                                                doses of rifampin, a strong CYP3A inducer, with a single 125 mg IBRANCE
                                                dose decreased palbociclib AUC<sub>INF</sub> and C<sub>max</sub> by 85%
                                                and 70%, respectively, relative to a single 125 mg IBRANCE dose given
                                                alone. Data from a drug interaction trial in healthy subjects (N=14)
                                                indicate that coadministration of multiple 400 mg daily doses of
                                                modafinil, a moderate CYP3A inducer, with a single 125 mg IBRANCE dose
                                                decreased palbociclib AUC<sub>INF</sub> and C<sub>max</sub> by 32% and
                                                11%, respectively, relative to a single 125 mg IBRANCE dose given alone
                                                <em>[see <a href="#S7.2">Drug Interactions (7.2)</a>]</em>.
                                            </p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="e53d9b50-9079-404d-93e8-8bc52258422d">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_3f1b74de-b2f9-4e5f-86ba-66f52fcd7435" />
                                </extension>
                                <code>
                                    <coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding>
                                </code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>CYP3A Substrates:</em> Palbociclib is a weak time-dependent inhibitor
                                                of CYP3A following daily 125 mg dosing to steady state in humans. In a
                                                drug interaction trial in healthy subjects (N=26), coadministration of
                                                midazolam with multiple doses of IBRANCE increased the midazolam
                                                AUC<sub>INF</sub> and the C<sub>max</sub> values by 61% and 37%,
                                                respectively, as compared to administration of midazolam alone <em>[see
                                                    <a href="#ID_RefS7.3">Drug Interactions (7.3)</a>]</em>.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="5fae2928-b44b-4bb8-a2b2-e0c4be9bf5e5">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_63d0958e-7db5-43e8-a376-b7020777084d" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>Gastric pH Elevating Medications:</em> In a drug interaction trial in
                                                healthy subjects, coadministration of a single 125 mg dose of IBRANCE
                                                with multiple doses of the proton pump inhibitor (PPI) rabeprazole under
                                                fed conditions decreased palbociclib C<sub>max</sub> by 41%, but had
                                                limited impact on AUC<sub>INF</sub> (13% decrease), when compared to a
                                                single dose of IBRANCE administered alone. Given the reduced effect on
                                                gastric pH of H2-receptor antagonists and local antacids compared to
                                                PPIs, the effect of these classes of acid-reducing agents on palbociclib
                                                exposure under fed conditions is expected to be minimal. Under fed
                                                conditions there is no clinically relevant effect of PPIs, H2-receptor
                                                antagonists, or local antacids on palbociclib exposure. In another
                                                healthy subject study, coadministration of a single dose of IBRANCE with
                                                multiple doses of the PPI rabeprazole under fasted conditions decreased
                                                palbociclib AUC<sub>INF</sub> and C<sub>max</sub> by 62% and 80%,
                                                respectively, when compared to a single dose of IBRANCE administered
                                                alone.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="cbf257e6-d7a6-4a7e-8221-61964f582b36">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_72a717cc-4787-4eb7-91eb-3eb2e727f0f5" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>Letrozole:</em> Data from a clinical trial in patients with breast
                                                cancer showed that there was no drug interaction between palbociclib and
                                                letrozole when the 2 drugs were coadministered.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="94ec5ed2-24e6-4f6e-b326-4f9497a8af91">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_b7588562-0f32-4d51-9873-a9d2613983a9" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>Fulvestrant:</em> Data from a clinical trial in patients with breast
                                                cancer showed that there was no clinically relevant drug interaction
                                                between palbociclib and fulvestrant when the 2 drugs were
                                                coadministered.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="1dfdbd72-6527-47eb-98e8-43268a652efb">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_1fc5b415-751c-48e6-ad14-4e1990bfaa30" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>Goserelin:</em> Data from a clinical trial in patients with breast
                                                cancer showed that there was no clinically relevant drug interaction
                                                between palbociclib and goserelin when the 2 drugs were coadministered.
                                            </p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="eafa95f2-1e1c-4e9d-a591-d71add1d7a0e">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2023-09-13" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_22344c82-2c70-4578-abf5-6577d5a8999e" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>Anastrozole or Exemestane:</em> No clinical data are available to
                                                evaluate drug interactions between anastrozole or exemestane and
                                                palbociclib. A clinically significant drug interaction between
                                                anastrozole or exemestane and palbociclib is not expected based on
                                                analyses of the effects of anastrozole, exemestane and palbociclib on or
                                                by metabolic pathways or transporter systems. </p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="590e27aa-fb95-4b9d-9b0b-2bd954ca367e">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_6e6a8663-a24b-4e09-bf86-1fb062a3459f" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>Effect of Palbociclib on Transporters:</em> In vitro evaluations
                                                indicated that palbociclib has a low potential to inhibit the activities
                                                of drug transporters organic anion transporter (OAT)1, OAT3, organic
                                                cation transporter (OCT)2, and organic anion transporting polypeptide
                                                (OATP)1B1, OATP1B3 at clinically relevant concentrations. In vitro,
                                                palbociclib has the potential to inhibit OCT1 at clinically relevant
                                                concentrations, as well as the potential to inhibit P-glycoprotein
                                                (P-gp) or breast cancer resistance protein (BCRP) in the
                                                gastrointestinal tract at the proposed dose.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                            <section id="953ac39b-d21b-4eb5-90da-b7df97de10dc">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2022-12-16" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_f0a320aa-4bd1-458b-8d38-9a0959b7d97f" />
                                </extension>
                                <code><coding>
										<system value="http://loinc.org"/>
										<code value="42229-5"/>
										<display value="SPL UNCLASSIFIED SECTION"/>
									</coding></code>
                                <text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p><em>Effect of Transporters on Palbociclib:</em> Based on in vitro data,
                                                P-gp and BCRP mediated transport are unlikely to affect the extent of
                                                oral absorption of palbociclib at therapeutic doses.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                    </section>
                </section>
                <section id="4228e56f-b41d-4fe2-8557-7ad91e941225">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S13" />
                    </extension>
                    <title value="13 NONCLINICAL TOXICOLOGY" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="43680-8"/>
							<display value="NONCLINICAL TOXICOLOGY SECTION"/>
						</coding></code>
                    <section id="4c2e5387-8460-41b4-be64-83e364eaa68c">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S13.1" />
                        </extension>
                        <title value="13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility" />
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="34083-6"/>
								<display value="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Palbociclib was assessed for carcinogenicity in a 6-month transgenic mouse study
                                        and in a 2-year rat study. Oral administration of palbociclib for 2 years
                                        resulted in an increased incidence of microglial cell tumors in the central
                                        nervous system of male rats at a dose of 30 mg/kg/day (approximately 8 times the
                                        human clinical exposure based on AUC). There were no neoplastic findings in
                                        female rats at doses up to 200 mg/kg/day (approximately 5 times the human
                                        clinical exposure based on AUC). Oral administration of palbociclib to male and
                                        female rasH2 transgenic mice for 6 months did not result in increased incidence
                                        of neoplasms at doses up to 60 mg/kg/day. </p>
                                    <p>Palbociclib was aneugenic in Chinese Hamster Ovary cells in vitro and in the bone
                                        marrow of male rats at doses â¥100 mg/kg/day for 3 weeks. Palbociclib was not
                                        mutagenic in an in vitro bacterial reverse mutation (Ames) assay and was not
                                        clastogenic in the in vitro human lymphocyte chromosome aberration assay.</p>
                                    <p>In a fertility study in female rats, palbociclib did not affect mating or
                                        fertility at any dose up to 300 mg/kg/day (approximately 4 times human clinical
                                        exposure based on AUC) and no adverse effects were observed in the female
                                        reproductive tissues in repeat-dose toxicity studies up to 300 mg/kg/day in the
                                        rat and 3 mg/kg/day in the dog (approximately 6 times and similar to human
                                        exposure [AUC], at the recommended dose, respectively).</p>
                                    <p>The adverse effects of palbociclib on male reproductive function and fertility
                                        were observed in the repeat-dose toxicology studies in rats and dogs and a male
                                        fertility study in rats. In repeat-dose toxicology studies, palbociclib-related
                                        findings in the testis, epididymis, prostate, and seminal vesicle at â¥30
                                        mg/kg/day in rats and â¥0.2 mg/kg/day in dogs included decreased organ weight,
                                        atrophy or degeneration, hypospermia, intratubular cellular debris, and
                                        decreased secretion. Partial reversibility of male reproductive organ effects
                                        was observed in the rat and dog following a 4- and 12-week non-dosing period,
                                        respectively. These doses in rats and dogs resulted in approximately â¥10 and 0.1
                                        times, respectively, the exposure [AUC] in humans at the recommended dose. In
                                        the fertility and early embryonic development study in male rats, palbociclib
                                        caused no effects on mating but resulted in a slight decrease in fertility in
                                        association with lower sperm motility and density at 100 mg/kg/day with
                                        projected exposure levels [AUC] of 20 times the exposure in humans at the
                                        recommended dose.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="c2d90216-4824-4206-b371-7043a5a6c5cb">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S14" />
                    </extension>
                    <title value="14 CLINICAL STUDIES" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="34092-7"/>
							<display value="CLINICAL STUDIES SECTION"/>
						</coding></code>
                    <section id="c0d9c060-e256-441e-bc3a-52af1fca7394">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_29bea950-7bcf-42e1-9949-707d585c16c2" />
                        </extension>
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">
                                        <strong>PALOMA-2: IBRANCE plus
                                            Letrozole</strong>
                                    </p>
                                </div>
                            </div>
                        </text>
                        <section id="7bb3e790-323e-43fb-b1c9-2264ad03243f">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-09-13" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_2ab9382f-1658-45a6-8a95-4066db0b92e3" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Patients with ER-positive, HER2-negative advanced or metastatic
                                                breast cancer for initial endocrine based therapy</strong>
                                        </p>
                                        <p>PALOMA-2 was an international, randomized, double-blind, parallel-group,
                                            multicenter study of IBRANCE plus letrozole versus placebo plus letrozole
                                            conducted in postmenopausal women with ER-positive, HER2-negative advanced
                                            breast cancer who had not received previous systemic treatment for their
                                            advanced disease. A total of 666 patients were randomized 2:1 to IBRANCE
                                            plus letrozole or placebo plus letrozole. Randomization was stratified by
                                            disease site (visceral versus non-visceral), disease-free interval (de novo
                                            metastatic versus â¤12 months from the end of adjuvant treatment to disease
                                            recurrence versus &gt;12 months from the end of adjuvant treatment to
                                            disease recurrence), and nature of prior (neo)adjuvant anticancer therapies
                                            (prior hormonal therapies versus no prior hormonal therapy). IBRANCE was
                                            given orally at a dose of 125 mg daily for 21 consecutive days followed by 7
                                            days off treatment. Patients received study treatment until objective
                                            disease progression, symptomatic deterioration, unacceptable toxicity,
                                            death, or withdrawal of consent, whichever occurred first. The major
                                            efficacy outcome of the study was investigator-assessed progression-free
                                            survival (PFS) evaluated according to Response Evaluation Criteria in Solid
                                            Tumors Version 1.1 (RECIST). Additional efficacy outcome measures were
                                            confirmed overall response rate (ORR) as assessed by the investigator
                                            according to RECIST Version 1.1 and overall survival (OS).</p>
                                        <p>Patients enrolled in this study had a median age of 62 years (range 28 to
                                            89). The majority of patients were White (78%), and most patients had an
                                            Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
                                            (98%). Forty-eight percent of patients had received chemotherapy and 56% had
                                            received antihormonal therapy in the neoadjuvant or adjuvant setting prior
                                            to their diagnosis of advanced breast cancer. Thirty-seven percent of
                                            patients had no prior systemic therapy in the neoadjuvant or adjuvant
                                            setting. The majority of patients (97%) had metastatic disease. Twenty-three
                                            percent of patients had bone only disease, and 49% of patients had visceral
                                            disease.</p>
                                        <p>Major efficacy results from PALOMA-2 are summarized in Table 8 and Figure 1.
                                            Consistent results were observed across patient subgroups of disease-free
                                            interval (DFI), disease site, and prior therapy. The treatment effect of the
                                            combination on PFS was also supported by an independent review of
                                            radiographs. Based on the prespecified final OS analysis conducted after 435
                                            events, OS was not statistically significant.</p>
                                        <table width="80%">
                                            <caption>Table 8. Efficacy Results â PALOMA-2</caption>
                                            <colgroup span="3">
                                                <col width="40%" />
                                                <col width="26%" />
                                                <col width="26%" />
                                            </colgroup>
                                            <thead>
                                                <tr>
                                                    <td style="text-align: left; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                        align="" />
                                                    <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                        align="">
                                                        <strong>IBRANCE plus Letrozole</strong>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                        align="">
                                                        <strong>Placebo plus Letrozole</strong>
                                                    </td>
                                                </tr>
                                            </thead>
                                            <tfoot>
                                                <tr>
                                                    <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                        colspan="3">CI=confidence interval; ITT=Intent-to-Treat;
                                                        N=number of patients; NE=not estimable; OS=overall survival;
                                                        PFS=progression-free survival.</td>
                                                </tr>
                                            </tfoot>
                                            <tbody>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                        <p>
                                                            <strong>Progression-free survival for ITT (investigator
                                                                assessment)</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=444</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=222</strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Number of PFS events (%)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">194 (43.7)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">137 (61.7)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Median progression-free survival (months, 95% CI)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">24.8 (22.1, NE)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">14.5 (12.9, 17.1)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Hazard ratio (95% CI) and p-value</p>
                                                    </td>
                                                    <td colspan="2"
                                                        style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">0.576 (0.463, 0.718)<a
                                                                href="#_Ref145336164" id="ID0ETIGM"
                                                                name="foot-ref-_Ref145336164">
                                                                <sup>2</sup>
                                                            </a>,
                                                            p&lt;0.0001<a href="#_Ref145336182" id="ID0ERJGM"
                                                                name="foot-ref-_Ref145336182">
                                                                <sup>3</sup>
                                                            </a></p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p>
                                                            <strong>Objective Response for patients with measurable
                                                                disease (investigator assessment)</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=338</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=171</strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Objective response rate<a href="#_RefID0EDSAI" id="ID0EPKGM"
                                                                name="foot-ref-_RefID0EDSAI">
                                                                <sup>4</sup>
                                                            </a> (%, 95%
                                                            CI)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">55.3 (49.9, 60.7)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">44.4 (36.9, 52.2)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p>
                                                            <strong>Overall survival for ITT </strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=444</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=222</strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Number of OS events (%) </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">287 (64.6)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">148 (66.7) </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Median OS (months, 95% CI) </p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">53.8 (49.8, 59.2)</p>
                                                    </td>
                                                    <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">49.8 (42.3, 56.4)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                        <p> Hazard ratio (95% CI) and pâvalue </p>
                                                    </td>
                                                    <td colspan="2"
                                                        style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">0.921 (0.755, 1.124)<a
                                                                href="#_Ref145336164" id="ID0ETIGM"
                                                                name="foot-ref-_Ref145336164">
                                                                <sup>2</sup>
                                                            </a>,
                                                            p=0.2087<a href="#_Ref145336182" id="ID0ERJGM"
                                                                name="foot-ref-_Ref145336182">
                                                                <sup>3</sup>
                                                            </a></p>
                                                    </td>
                                                </tr>
                                            </tbody>
                                        </table>
                                        <p><sup>
                                                <a name="_Ref145336164" href="#foot-ref-_Ref145336164">1</a>
                                            </sup>Cox
                                            proportional hazards model stratified by disease site (visceral vs.
                                            non-visceral) per randomization.</p>
                                        <p><sup>
                                                <a name="_Ref145336182" href="#foot-ref-_Ref145336182">2</a>
                                            </sup>Stratified log-rank test
                                            one-sided p-value.</p>
                                        <p><sup>
                                                <a name="_RefID0EDSAI" href="#foot-ref-_RefID0EDSAI">3</a>
                                            </sup>Response
                                            is based on confirmed responses.</p>
                                        <table width="100%">
                                            <colgroup span="1">
                                                <col width="100%" />
                                            </colgroup>
                                            <tbody>
                                                <tr>
                                                    <td style="text-align: center; text-align: center; " align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>Figure 1. Kaplan-Meier
                                                                Plot of Progression-Free Survival â PALOMA-2
                                                                (Investigator Assessment, Intent-to-Treat
                                                                Population)</strong>
                                                            <br />
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td style="text-align: center; text-align: center; " align="center">
                                                        <img src="#ibrance-02" alt="Figure 1" />
                                                        <p style="text-align: center; ">LET=letrozole; PAL=palbociclib;
                                                            PBO=placebo.</p>
                                                    </td>
                                                </tr>
                                            </tbody>
                                        </table>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="db06e919-8ce9-488b-b3b2-89aef9fb9799">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_ff1dbb54-5d01-4a5a-9114-ed57a1228530" />
                        </extension>
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">
                                        <strong>PALOMA-3: IBRANCE plus
                                            Fulvestrant</strong>
                                    </p>
                                </div>
                            </div>
                        </text>
                        <section id="9df8e491-bd93-4bc9-bfd2-e09116da0793">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-09-13" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_29c7f77b-b24d-4850-b048-9cc5c9a8fe67" />
                            </extension>
                            <code><coding>
									<system value="http://loinc.org"/>
									<code value="42229-5"/>
									<display value="SPL UNCLASSIFIED SECTION"/>
								</coding></code>
                            <text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p>
                                            <strong>Patients with HR-positive, HER2-negative advanced or metastatic
                                                breast cancer who have had disease progression on or after prior
                                                adjuvant or metastatic endocrine therapy</strong>
                                        </p>
                                        <p>PALOMA-3 was an international, randomized, double-blind, parallel group,
                                            multicenter study of IBRANCE plus fulvestrant versus placebo plus
                                            fulvestrant conducted in women with HR-positive, HER2-negative advanced
                                            breast cancer, regardless of their menopausal status, whose disease
                                            progressed on or after prior endocrine therapy. A total of 521
                                            pre/postmenopausal women were randomized 2:1 to IBRANCE plus fulvestrant or
                                            placebo plus fulvestrant and stratified by documented sensitivity to prior
                                            hormonal therapy, menopausal status at study entry (pre/peri versus
                                            postmenopausal), and presence of visceral metastases. IBRANCE was given
                                            orally at a dose of 125 mg daily for 21 consecutive days followed by 7 days
                                            off treatment. Pre/perimenopausal women were enrolled in the study and
                                            received the LHRH agonist goserelin for at least 4 weeks prior to and for
                                            the duration of PALOMA-3. Patients continued to receive assigned treatment
                                            until objective disease progression, symptomatic deterioration, unacceptable
                                            toxicity, death, or withdrawal of consent, whichever occurred first. The
                                            major efficacy outcome of the study was investigator-assessed PFS evaluated
                                            according to RECIST 1.1.</p>
                                        <p>Patients enrolled in this study had a median age of 57 years (range 29 to
                                            88). The majority of patients on study were White (74%), all patients had an
                                            ECOG PS of 0 or 1, and 80% were postmenopausal. All patients had received
                                            prior systemic therapy, and 75% of patients had received a previous
                                            chemotherapy regimen. Twenty-five percent of patients had received no prior
                                            therapy in the metastatic disease setting, 60% had visceral metastases, and
                                            23% had bone only disease.</p>
                                        <p>The results from the investigator-assessed PFS and final OS from PALOMA-3 are
                                            summarized in Table 9. The relevant Kaplan-Meier plots are shown in Figures
                                            2 and 3, respectively. Consistent PFS results were observed across patient
                                            subgroups of disease site, sensitivity to prior hormonal therapy, and
                                            menopausal status. After a median follow-up time of 45 months, the final OS
                                            results were not statistically significant.</p>
                                        <table width="80%">
                                            <caption>Table 9. Efficacy Results â PALOMA-3</caption>
                                            <colgroup span="3">
                                                <col width="40%" />
                                                <col width="26%" />
                                                <col width="26%" />
                                            </colgroup>
                                            <thead>
                                                <tr>
                                                    <td style="text-align: left; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                        align="" />
                                                    <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                        align="">
                                                        <strong>IBRANCE plus Fulvestrant</strong>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                        align="">
                                                        <strong>Placebo plus Fulvestrant</strong>
                                                    </td>
                                                </tr>
                                            </thead>
                                            <tfoot>
                                                <tr>
                                                    <td style="text-align: left; vertical-align: top; border-bottom: solid"
                                                        colspan="3">CI=confidence interval; ITT=Intent-to-Treat;
                                                        N=number of patients; OS=overall survival; PFS=progression-free
                                                        survival.</td>
                                                </tr>
                                            </tfoot>
                                            <tbody>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                        <p>
                                                            <strong>Progression-free survival for
                                                                ITT</strong>
                                                            <br />
                                                            <strong>(investigator
                                                                assessment)</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=347</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=174</strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Number of PFS events (%)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">145 (41.8)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">114 (65.5)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Median PFS (months, 95% CI)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">9.5 (9.2, 11.0)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">4.6 (3.5, 5.6)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Hazard ratio (95% CI) and p-value</p>
                                                    </td>
                                                    <td colspan="2"
                                                        style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">0.461 (0.360, 0.591),
                                                            p&lt;0.0001</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p>
                                                            <strong>Objective Response for patients with measurable
                                                                disease</strong>
                                                            <br />
                                                            <strong>(investigator
                                                                assessment)</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=267</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=138</strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Objective response rate<a href="#_RefID0EDXAI" id="ID0EMXHM"
                                                                name="foot-ref-_RefID0EDXAI">
                                                                <sup>2</sup>
                                                            </a> (%, 95%
                                                            CI)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">24.6 (19.6, 30.2)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">10.9 (6.2, 17.3)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p>
                                                            <strong>Overall survival for ITT </strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=347</strong>
                                                        </p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>N=174</strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Number of OS events (%)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">201 (57.9)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">109 (62.6)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                        <p> Median OS (months, 95% CI)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">34.9 (28.8, 40.0)</p>
                                                    </td>
                                                    <td style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">28.0 (23.6, 34.6)</p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td
                                                        style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                        <p> Hazard ratio (95% CI) and p-value</p>
                                                    </td>
                                                    <td colspan="2"
                                                        style="text-align: center; vertical-align: middle; border-right: solid; border-bottom: solid; text-align: center; "
                                                        align="center">
                                                        <p style="text-align: center; ">0.814 (0.644, 1.029), p=0.0857<a
                                                                href="#_RefID0EOYAI" id="ID0EFYHM"
                                                                name="foot-ref-_RefID0EOYAI">
                                                                <sup>3</sup>
                                                            </a><a href="#_RefID0EPYAI" id="ID0E5YHM"
                                                                name="foot-ref-_RefID0EPYAI">
                                                                <sup>4</sup>
                                                            </a></p>
                                                    </td>
                                                </tr>
                                            </tbody>
                                        </table>
                                        <p><sup>
                                                <a name="_RefID0EDXAI" href="#foot-ref-_RefID0EDXAI">1</a>
                                            </sup>Responses are based on
                                            confirmed responses.</p>
                                        <p><sup>
                                                <a name="_RefID0EOYAI" href="#foot-ref-_RefID0EOYAI">2</a>
                                            </sup>Not
                                            statistically significant at the pre-specified 2-sided alpha level of 0.047.
                                        </p>
                                        <p><sup>
                                                <a name="_RefID0EPYAI" href="#foot-ref-_RefID0EPYAI">3</a>
                                            </sup>2-sided
                                            p-value from the log-rank test stratified by the presence of visceral
                                            metastases and sensitivity to prior endocrine therapy per randomization.</p>
                                        <table width="100%">
                                            <colgroup span="1">
                                                <col width="100%" />
                                            </colgroup>
                                            <tbody>
                                                <tr>
                                                    <td style="text-align: center; text-align: center; " align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>Figure 2. Kaplan-Meier
                                                                Plot of Progression-Free Survival â PALOMA-3
                                                                (Investigator Assessment, Intent-to-Treat Population)
                                                            </strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td style="text-align: left; text-align: left; ">
                                                        <img src="#ibrance-03" alt="Figure 2" />
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td style="text-align: center; text-align: center; " align="center">
                                                        <p style="text-align: center; ">FUL=fulvestrant;
                                                            PAL=palbociclib; PBO=placebo.</p>
                                                    </td>
                                                </tr>
                                            </tbody>
                                        </table>
                                        <table width="100%">
                                            <colgroup span="1">
                                                <col width="100%" />
                                            </colgroup>
                                            <tbody>
                                                <tr>
                                                    <td style="text-align: center; text-align: center; " align="center">
                                                        <p style="text-align: center; ">
                                                            <strong>Figure 3. Kaplan-Meier
                                                                Plot of Overall Survival (Intent-to-Treat Population) â
                                                                PALOMA-3</strong>
                                                        </p>
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td style="text-align: left; text-align: left; ">
                                                        <img src="#ibrance-04" alt="Figure 3" />
                                                    </td>
                                                </tr>
                                                <tr>
                                                    <td style="text-align: center; text-align: center; " align="center">
                                                        <p style="text-align: center; ">FUL=fulvestrant;
                                                            PAL=palbociclib; PBO=placebo.</p>
                                                    </td>
                                                </tr>
                                            </tbody>
                                        </table>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                </section>
                <section id="8fcab495-04e5-4543-b37c-72343608324b">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S16" />
                    </extension>
                    <title value="16 HOW SUPPLIED/STORAGE AND HANDLING" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="34069-5"/>
							<display value="HOW SUPPLIED SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>IBRANCE is supplied in the following strengths and package configurations:</p>
                                <table width="75%">
                                    <colgroup span="4">
                                        <col width="19%" />
                                        <col width="18%" />
                                        <col width="18%" />
                                        <col width="32%" />
                                    </colgroup>
                                    <thead>
                                        <tr>
                                            <td colspan="4"
                                                style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; text-align: center; font-weight: bold; "
                                                align="">
                                                <strong>IBRANCE Capsules</strong>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="text-align: center; vertical-align: top; border-right: solid; border-left: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                align="">
                                                <strong>Package Configuration</strong>
                                            </td>
                                            <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                align="">
                                                <strong>Capsule Strength (mg)</strong>
                                            </td>
                                            <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                align="">
                                                <strong>NDC</strong>
                                            </td>
                                            <td style="text-align: center; vertical-align: top; border-right: solid; border-bottom: solid; text-align: center; font-weight: bold; "
                                                align="">
                                                <strong>Capsule Description</strong>
                                            </td>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td
                                                style="text-align: left; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                <p>Bottles of 21 capsules</p>
                                            </td>
                                            <td style="text-align: center; border-right: solid; border-top: solid; border-bottom: solid; text-align: center; "
                                                align="center">
                                                <p style="text-align: center; ">125</p>
                                            </td>
                                            <td
                                                style="text-align: left; border-right: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                <p>NDC 0069-0189-21</p>
                                            </td>
                                            <td
                                                style="text-align: left; border-right: solid; border-top: solid; border-bottom: solid; text-align: left; ">
                                                <p>opaque, hard gelatin capsules, size 0, with caramel cap and body,
                                                    printed with white ink "Pfizer" on the cap, "PBC 125" on the body
                                                </p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="text-align: left; border-right: solid; border-left: solid; border-bottom: solid; text-align: left; ">
                                                <p>Bottles of 21 capsules</p>
                                            </td>
                                            <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                align="center">
                                                <p style="text-align: center; ">100</p>
                                            </td>
                                            <td
                                                style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                <p>NDC 0069-0188-21</p>
                                            </td>
                                            <td
                                                style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                <p>opaque, hard gelatin capsules, size 1, with caramel cap and light
                                                    orange body, printed with white ink "Pfizer" on the cap, "PBC 100"
                                                    on the body</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="text-align: left; border-right: solid; border-bottom: solid; border-left: solid; text-align: left; ">
                                                <p>Bottles of 21 capsules</p>
                                            </td>
                                            <td style="text-align: center; border-right: solid; border-bottom: solid; text-align: center; "
                                                align="center">
                                                <p style="text-align: center; ">75</p>
                                            </td>
                                            <td
                                                style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                <p>NDC 0069-0187-21</p>
                                            </td>
                                            <td
                                                style="text-align: left; border-right: solid; border-bottom: solid; text-align: left; ">
                                                <p>opaque, hard gelatin capsules, size 2, with light orange cap and
                                                    body, printed with white ink "Pfizer" on the cap, "PBC 75" on the
                                                    body</p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </text>
                    <section id="55cb2eff-8674-4120-a695-9bccc5108df0">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_8d706147-d726-49bd-a7da-1fbbb568fac3" />
                        </extension>
                        <code>
                            <coding>
								<system value="http://loinc.org"/>
								<code value="44425-7"/>
								<display value="STORAGE AND HANDLING SECTION"/>
							</coding>
                        </code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Store at 20 Â°C to 25 Â°C (68 Â°F to 77 Â°F); excursions permitted between 15 Â°C to
                                        30 Â°C (59 Â°F to 86 Â°F) <em>[see USP Controlled Room Temperature]</em>.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="e136306a-8b01-4e5f-a8ed-5e2b06c65bf6">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S17" />
                    </extension>
                    <title value="17 PATIENT COUNSELING INFORMATION" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="34076-0"/>
							<display value="INFORMATION FOR PATIENTS SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>Advise the patient to read the FDA-approved patient labeling (Patient Information).
                                </p>
                            </div>
                        </div>
                    </text>
                    <section id="5ff5f17f-2b9c-4482-9ab7-aa03d4689546">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_1a099017-6dc8-44e0-af70-fc88f31ead62" />
                        </extension>
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">Myelosuppression/Infection</p>
                                    <ul>
                                        <li>Advise patients to immediately report any signs or symptoms of
                                            myelosuppression or infection, such as fever, chills, dizziness, shortness
                                            of breath, weakness, or any increased tendency to bleed and/or to bruise
                                            <em>[see <a href="#ID_RefS5.1">Warnings and Precautions (5.1)</a>]</em>.
                                        </li>
                                    </ul>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="895558de-9304-4fe6-8a5e-50db0469e40f">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_a7b6293a-387c-44c8-8ead-0e0ac64be7fa" />
                        </extension>
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">Interstitial Lung Disease/Pneumonitis</p>
                                    <ul>
                                        <li>Advise patients to immediately report new or worsening respiratory symptoms
                                            <em>[see <a href="#ID_RefS5.2">Warnings and Precautions (5.2)</a>]</em>.
                                        </li>
                                    </ul>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="f214d264-3c6a-401a-ad6b-76fb7200b23e">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_af911acf-785f-42b3-9f00-cb3d7e10727c" />
                        </extension>
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">Drug Interactions</p>
                                    <ul>
                                        <li>Grapefruit may interact with IBRANCE. Patients should not consume grapefruit
                                            products while on treatment with IBRANCE.</li>
                                        <li>Inform patients to avoid strong CYP3A inhibitors and strong CYP3A inducers.
                                        </li>
                                        <li>Advise patients to inform their healthcare providers of all concomitant
                                            medications, including prescription medicines, over-the-counter drugs,
                                            vitamins, and herbal products <em>[see <a href="#S7.3">Drug Interactions
                                                    (7)</a>]</em>.</li>
                                    </ul>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="1fa3bf44-58c4-4368-b461-17814ecf47bb">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_ff694ed3-9a30-49e2-b55a-c2d524650207" />
                        </extension>
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">Dosing and Administration</p>
                                    <ul>
                                        <li>Advise patients to take IBRANCE with food.</li>
                                        <li>If the patient vomits or misses a dose, an additional dose should not be
                                            taken. The next prescribed dose should be taken at the usual time. IBRANCE
                                            capsules should be swallowed whole (do not chew, crush, or open them prior
                                            to swallowing). No capsule should be ingested if it is broken, cracked, or
                                            otherwise not intact.</li>
                                        <li>Pre/perimenopausal women treated with IBRANCE should also be treated with
                                            LHRH agonists <em>[see <a href="#ID_RefS2.1">Dosage and Administration
                                                    (2.1)</a>]</em>.</li>
                                    </ul>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="e3c1b586-a6d8-4d21-8471-0106ace3b4df">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2022-12-16" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_22f0f644-1d0f-4247-97c9-baf21a95dfe7" />
                        </extension>
                        <code><coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding></code>
                        <text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">Pregnancy, Lactation, and Infertility</p>
                                    <ul>
                                        <li>Embryo-Fetal Toxicity<ul>
                                                <li>Advise females of reproductive potential of the potential risk to a
                                                    fetus and to use effective contraception during treatment with
                                                    IBRANCE therapy and for at least 3 weeks after the last dose. Advise
                                                    females to inform their healthcare provider of a known or suspected
                                                    pregnancy <em>[see <a href="#ID_RefS5.3">Warnings and Precautions
                                                            (5.3)</a> and <a href="#ID_RefS8.1">Use in Specific
                                                            Populations (8.1</a> and <a
                                                            href="#ID_RefS8.3">8.3)</a>]</em>.</li>
                                                <li>Advise male patients with female partners of reproductive potential
                                                    to use effective contraception during treatment with IBRANCE and for
                                                    at least 3 months after the last dose <em>[see <a
                                                            href="#ID_RefS8.3">Use in Specific Populations
                                                            (8.3)</a>].</em></li>
                                            </ul>
                                        </li>
                                        <li>Lactation: Advise women not to breastfeed during treatment with IBRANCE and
                                            for 3 weeks after the last dose <em>[see <a href="#ID_RefS8.2">Use in
                                                    Specific Populations (8.2)</a>].</em></li>
                                        <li>Infertility: Inform males of reproductive potential that IBRANCE may cause
                                            infertility and to consider sperm preservation before taking IBRANCE
                                            <em>[see <a href="#ID_RefS8.3">Use in Specific Populations (8.3)</a>]</em>.
                                        </li>
                                    </ul>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="43098084-9d31-4740-8dbe-a8047dc93991">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_f946f55b-354f-4a40-9285-42ca1b237573" />
                    </extension>
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="42229-5"/>
							<display value="SPL UNCLASSIFIED SECTION"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>This product's label may have been updated. For full prescribing information, please
                                    visit <a href="http://www.Pfizer.com">www.Pfizer.com</a>. For medical information
                                    about IBRANCE, please visit <a
                                        href="http://www.pfizermedinfo.com">www.pfizermedinfo.com</a> or call
                                    1-800-438-1985.</p>
                                <img src="#ibrance-05" alt="Pfizer Logo 1" />
                                <p>LAB-0723-10.0</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="3fd15a64-1a72-42ca-ae98-634985054cc7">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-09-13" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_6b75646a-2a17-41f0-972d-bf9a7bcc1e10" />
                    </extension>
                    <title value="SPL PATIENT PACKAGE INSERT SECTION" />
                    <code>
						<coding>
							<system value="http://loinc.org"/>
							<code value="42230-3"/>
							<display value="SPL PATIENT PACKAGE INSERT SECTION"/>
						</coding>
					</code>
                    <section>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <id value="NESTED-SECTION-1" />
                        <title value="PATIENT INFORMATION" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p><b>IBRANCE <sup>Â®</sup> (EYE-brans)</b></p> 
                                <p><b>(palbociclib)</b></p>
                                <p>Capsules</p>
                            </div>
                        </text>
                    </section>
                    <section id="82a5a3bb-c2d4-4a6f-b911-abe9bc1a7c81">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <title value="What is the most important information I should know about IBRANCE?" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>
                                    <b>IBRANCE may cause serious side effects, including:</b>
                                </p>
                                <p>
                                    <b>Low white blood cell counts (neutropenia).</b> Low white
                                    blood cell counts are very common when taking IBRANCE and may
                                    cause serious infections that can lead to death. Your healthcare
                                    provider should check your white blood cell counts before and
                                    during treatment.
                                </p>
                                <p>
                                    If you develop low white blood cell counts during treatment with
                                    IBRANCE, your healthcare provider may stop your treatment,
                                    decrease your dose, or may tell you to wait to begin your
                                    treatment cycle. Tell your healthcare provider right away if you
                                    have signs and symptoms of low white blood cell counts or
                                    infections such as fever and chills.
                                </p>
                                <p>
                                    <b>Lung problems (pneumonitis).</b> IBRANCE may cause severe or
                                    life-threatening inflammation of the lungs during treatment that
                                    can lead to death. Tell your healthcare provider right away if
                                    you have any new or worsening symptoms, including:
                                </p>
                                <ul>
                                    <li>chest pain</li>
                                    <li>cough with or without mucus</li>
                                    <li>trouble breathing or shortness of breath</li>
                                </ul>
                                <p>
                                    Your healthcare provider may interrupt or stop treatment with
                                    IBRANCE completely if your symptoms are severe.
                                </p>
                                <p>
                                    <b> See <a href="#What are the possible side effects of IBRANCE?">"What are the possible side effects of
                                            IBRANCE?"</a> for more information about side effects. </b>
                                </p>
                            </div>
                        </text>
                    </section>
                    <section id="bd4efcd9-c565-4357-bd74-db65f8d9d2a8">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <id value="NESTED-SECTION-3" />
                        <title value="What is IBRANCE?" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>
                                    IBRANCE is a prescription medicine used in adults to treat
                                    hormone receptor (HR)-positive, human epidermal growth factor
                                    receptor 2 (HER2)-negative breast cancer that has spread to
                                    other parts of the body (metastatic) in combination with:
                                </p>
                                <ul>
                                    <li>an aromatase inhibitor as the first hormonal based therapy
                                        in postmenopausal women or in men, or</li>
                                    <li>fulvestrant in people with disease progression following
                                        hormonal therapy.</li>
                                </ul>
                                <p>
                                    It is not known if IBRANCE is safe and effective in children.
                                </p>
                            </div>
                        </text>
                    </section>
                    <section id="8f1f3623-9f83-4e27-8d5a-1f0cc6a9d651">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <title
                            value="What should I tell my healthcare provider before taking IBRANCE?" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>Before taking IBRANCE, tell your healthcare provider about all of your medical conditions, including if you:</p>
                                <ul>
                                    <li>have fever, chills, or any other signs or symptoms of
                                        infection.</li>
                                    <li>have liver or kidney problems.</li>
                                    <li>are pregnant, or plan to become pregnant. IBRANCE can harm
                                        your unborn baby.</li>
                                    <li>
                                        <ul>
                                            <li><b>Females</b> who are able to become pregnant should use
                                                effective birth control during treatment and for at
                                                least 3 weeks after the last dose of IBRANCE. Your
                                                healthcare provider may ask you to take a pregnancy
                                                test before you start treatment with IBRANCE.</li>
                                            <li><b>Males</b> with female partners who can become pregnant
                                                should use effective birth control during treatment
                                                with IBRANCE for at least 3 months after the last
                                                dose of IBRANCE.</li>
                                            <li>Talk to your healthcare provider about birth control
                                                methods that may be right for you during this time.</li>
                                            <li>If you become pregnant or think you are pregnant,
                                                tell your healthcare provider right away.</li>
                                        </ul>
                                    </li>
                                    <li>are breastfeeding or plan to breastfeed. It is not known if
                                        IBRANCE passes into your breast milk. Do not breastfeed
                                        during treatment with IBRANCE and for 3 weeks after the last
                                        dose.</li>
                                </ul>
                                <p>
                                    <b>Tell your healthcare provider about all of the medicines you
                                        take, including</b> prescription and over-the-counter medicines,
                                    vitamins, and herbal supplements. IBRANCE and other medicines
                                    may affect each other causing side effects.
                                </p>
                            </div>
                        </text>
                    </section>
                    <section id="f323ca65-200c-4229-ba94-10852b0a2a11">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <title value="How should I take IBRANCE?" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <ul>
                                    <li>Take IBRANCE exactly as your healthcare provider tells you.</li>
                                    <li>Take IBRANCE with food.</li>
                                    <li>IBRANCE should be taken at about the same time each day.</li>
                                    <li>Swallow IBRANCE capsules whole. Do not chew, crush or open IBRANCE capsules
                                        before swallowing them.</li>
                                    <li>Do not take any IBRANCE capsules that are broken, cracked, or that look damaged.
                                    </li>
                                    <li>Avoid grapefruit and grapefruit products during treatment with IBRANCE.
                                        Grapefruit may increase the amount of IBRANCE in your blood.</li>
                                    <li>Do not change your dose or stop taking IBRANCE unless your healthcare provider
                                        tells you.</li>
                                    <li>If you miss a dose of IBRANCE or vomit after taking a dose of IBRANCE, do not
                                        take another dose on that day. Take your next dose at your regular time.</li>
                                    <li>If you take too much IBRANCE, call your healthcare provider right away or go to
                                        the nearest hospital emergency room.</li>
                                </ul>
                            </div>
                        </text>
                    </section>
                    <section id="4c58d3b9-16c5-45f8-bb9d-d40c59b8df76">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <title value="What are the possible side effects of IBRANCE?" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>
                                    <b> IBRANCE may cause serious side effects. See <a href="#82a5a3bb-c2d4-4a6f-b911-abe9bc1a7c81">"What
                                            is the most important information I should know about
                                            IBRANCE?"</a>
                                    </b>
                                </p>
                                <p>
                                    <b>The most common side effects of IBRANCE when used with either
                                        letrozole or fulvestrant include:</b>
                                </p>
                                <ul>
                                    <li> Low red blood cell counts and low platelet counts are
                                        common with IBRANCE. Call your healthcare provider right
                                        away if you develop any of these symptoms during treatment: 
                                        <ul>
                                            <li>dizziness</li>
                                            <li>shortness of breath</li>
                                            <li>weakness</li>
                                            <li>bleeding or bruising more easily</li>
                                            <li>nosebleeds</li>
                                        </ul>
                                    </li>
                                    <li> infections (see <a href="">"What is the most important
                                            information I should know about IBRANCE?</a>") </li>
                                    <li>tiredness</li>
                                    <li>nausea</li>
                                    <li>sore mouth</li>
                                    <li>abnormalities in liver blood tests</li>
                                    <li>diarrhea</li>
                                    <li>hair thinning or hair loss</li>
                                    <li>vomiting</li>
                                    <li>rash</li>
                                    <li>loss of appetite</li>
                                </ul>
                                <p>
                                    IBRANCE may cause fertility problems in males. This may affect
                                    your ability to father a child. Talk to your healthcare provider
                                    about family planning options before starting IBRANCE if this is
                                    a concern for you.
                                </p>
                                <p>
                                    These are not all of the possible side effects of IBRANCE.
                                </p>
                                <p>
                                    Call your doctor for medical advice about side effects. You may
                                    report side effects to FDA at 1-800-FDA-1088.
                                </p>
                            </div>
                        </text>
                    </section>
                    <section id="a419819a-6d01-4a72-9564-3458a117c741">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <title value="How should I store IBRANCE?" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <ul>
                                    <li>Store IBRANCE at 68 Â°F to 77 Â°F (20 Â°C to 25 Â°C) in the
                                        original blister pack.</li>
                                </ul>
                                <p>
                                    <b>Keep IBRANCE and all medicines out of the reach of children.</b>
                                </p>
                            </div>
                        </text>
                    </section>
                    <section id="0a3a2d68-6872-4ef9-b360-fe6741c9fcd4">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <title value="General information about the safe and effective use of IBRANCE" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>
                                    Medicines are sometimes prescribed for purposes other than those
                                    listed in a Patient Information leaflet. Do not use IBRANCE for
                                    a condition for which it was not prescribed. Do not give IBRANCE
                                    to other people, even if they have the same symptoms you have.
                                    It may harm them. You can ask your pharmacist or healthcare
                                    provider for more information about IBRANCE that is written for
                                    health professionals.
                                </p>
                            </div>
                        </text>
                    </section>
                    <section id="619ed04c-1aec-4749-8cf4-34b3f97e2d4f">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-09-13" />
                        </extension>
                        <title value="What are the ingredients in IBRANCE?" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <text>
                            <status value="generated" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <p>Active ingredient: palbociclib</p>

                                <p>Inactive ingredients: microcrystalline cellulose, lactose monohydrate, sodium starch
                                    glycolate, colloidal silicon dioxide, magnesium stearate, and hard gelatin capsule
                                    shells.</p>

                                <p>The light orange, light orange/caramel and caramel opaque capsule shells contain:
                                    gelatin, red iron oxide, yellow iron oxide, and titanium dioxide.</p>

                                <p>The printing ink contains: shellac, titanium dioxide, ammonium hydroxide, propylene
                                    glycol, and simethicone.</p>

                                <p>This productâs labeling may have been updated. For the most recent prescribing
                                    information, please visit <a href="http://www.pfizer.com">www.pfizer.com</a>.</p>
                                <p>
                                    <img src="#ibrance-05" alt="Pfizer Logo" />
                                </p>
                                <p>
                                    LAB-0724-8.0
                                </p>
                                <p>
                                    For more information, go to <a href="http://www.pfizer.com">WWW.PFIZER.COM</a>. or
                                    call 1-800-438-1985.
                                </p>

                            </div>
                        </text>
                    </section>
                </section>
                <section id="b72a24fd-4e71-469c-9aa8-7f3613d1ea9c">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_6640ddbd-9e6f-4e34-a48a-d0d4a14b80e0" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 75 mg Capsule Bottle Label" />
                    <code>
                        <coding>
							<system value="http://loinc.org"/>
							<code value="51945-4"/>
							<display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
						</coding>
                    </code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0069-0187-21</p>
                                <p>
                                    <strong>
                                        <em>Pfizer</em>
                                    </strong>
                                </p>
                                <p>
                                    <strong>Ibrance</strong>
                                    <sup>Â®</sup>
                                    <br />
                                    <strong>(palbociclib)</strong>
                                    <br />
                                    <strong>capsules</strong>
                                </p>
                                <p>
                                    <strong>75 mg</strong>
                                </p>
                                <p>21 Capsules</p>
                                <p>
                                    <strong>Rx only</strong>
                                </p>
                                <img src="#ibrance-07" alt="PRINCIPAL DISPLAY PANEL - 75 mg Capsule Bottle Label" />
                            </div>
                        </div>
                    </text>
                </section>
                <section id="ff1b9268-8429-45f6-acf8-1cc52f63ea81">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_92772f40-36b2-4483-9694-fd83bbcbd906" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="51945-4"/>
							<display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0069-0188-21</p>
                                <p>
                                    <strong>
                                        <em>Pfizer</em>
                                    </strong>
                                </p>
                                <p>
                                    <strong>Ibrance</strong>
                                    <sup>Â®</sup>
                                    <br />
                                    <strong>(palbociclib)</strong>
                                    <br />
                                    <strong>capsules</strong>
                                </p>
                                <p>
                                    <strong>100 mg</strong>
                                </p>
                                <p>21 Capsules</p>
                                <p>
                                    <strong>Rx only</strong>
                                </p>
                                <img src="#ibrance-08" alt="PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label" />
                            </div>
                        </div>
                    </text>
                </section>
                <section id="9cc58f8b-795a-43dc-a58a-226bccea0e32">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2022-12-16" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_b089e9cb-ee02-4eb4-bafe-4e06d8bd4bfc" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 125 mg Capsule Bottle Label" />
                    <code><coding>
							<system value="http://loinc.org"/>
							<code value="51945-4"/>
							<display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
						</coding></code>
                    <text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0069-0189-21</p>
                                <p>
                                    <strong>
                                        <em>Pfizer</em>
                                    </strong>
                                </p>
                                <p>
                                    <strong>Ibrance</strong>
                                    <sup>Â®</sup>
                                    <br />
                                    <strong>(palbociclib)</strong>
                                    <br />
                                    <strong>capsules</strong>
                                </p>
                                <p>
                                    <strong>125 mg</strong>
                                </p>
                                <p>21 Capsules</p>
                                <p>
                                    <strong>Rx only</strong>
                                </p>
                                <img src="#ibrance-09" alt="PRINCIPAL DISPLAY PANEL - 125 mg Capsule Bottle Label" />
                            </div>
                        </div>
                    </text>
                </section>
                <section id="eceba63e-59e8-49b9-bd20-510df0c31795">
                    <text>
                        <title value="Annotations" />
                        <code>
							<coding>
								<system value="http://loinc.org"/>
								<code value="42229-5"/>
								<display value="SPL UNCLASSIFIED SECTION"/>
							</coding>
						</code>
                        <status value="additional" />
                        <div class="comments" xmlns="http://www.w3.org/1999/xhtml" />
                        <div class="trackChanges" xmlns="http://www.w3.org/1999/xhtml">
                            <div class="Delete" title="del01">
                                <span class="Author" title="Pfizer" />
                                <span class="Date" title="2024-11-25T10:00:00Z" />
                            </div>
                        </div>
                    </text>
                </section>
            </Composition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Organization/134489525" />
        <resource>
            <Organization>
                <id value="134489525" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedLabeler" />
                </meta>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="134489525" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" />
                        <code value="Labeler" />
                    </coding>
                </type>
                <name value="Pfizer Laboratories Div Pfizer Inc" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Organization/618054084" />
        <resource>
            <Organization>
                <id value="618054084" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedEstablishment" />
                </meta>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="618054084" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" />
                        <code value="Establishment" />
                    </coding>
                </type>
                <name value="Pharmacia &amp; Upjohn Company LLC (DUNS: 618054084)" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Organization/985052076" />
        <resource>
            <Organization>
                <id value="985052076" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedEstablishment" />
                </meta>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="985052076" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" />
                        <code value="Establishment" />
                    </coding>
                </type>
                <name value="Pfizer Ireland Pharmaceuticals (DUNS: 985052076)" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Organization/341970073" />
        <resource>
            <Organization>
                <id value="341970073" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedEstablishment" />
                </meta>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="341970073" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" />
                        <code value="Establishment" />
                    </coding>
                </type>
                <name value="Pfizer Manufacturing Deutschland GmbH (DUNS: 341970073)" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Organization/936889401" />
        <resource>
            <Organization>
                <id value="936889401" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedEstablishment" />
                </meta>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="936889401" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" />
                        <code value="Establishment" />
                    </coding>
                </type>
                <name value="Pfizer Asia Manufacturing Pte Ltd (DUNS: 936889401)" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/LACTOSE_MONOHYDRATE" />
        <resource>
            <Ingredient>
                <id value="LACTOSE_MONOHYDRATE" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="EWQ57Q8I5X" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="true" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="EWQ57Q8I5X"/>
								<display value="LACTOSE MONOHYDRATE"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/SODIUM_STARCH_GLYCOLATE_TYPE_A_POTATO" />
        <resource>
            <Ingredient>
                <id value="SODIUM_STARCH_GLYCOLATE_TYPE_A_POTATO" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="5856J3G2A2" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="5856J3G2A2"/>
								<display value="SODIUM STARCH GLYCOLATE TYPE A POTATO"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/GELATIN_UNSPECIFIED" />
        <resource>
            <Ingredient>
                <id value="GELATIN_UNSPECIFIED" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="2G86QN327L" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="true" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="2G86QN327L"/>
								<display value="GELATIN, UNSPECIFIED"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/FERRIC_OXIDE_YELLOW" />
        <resource>
            <Ingredient>
                <id value="FERRIC_OXIDE_YELLOW" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="EX438O2MRT" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="EX438O2MRT"/>
								<display value="FERRIC OXIDE YELLOW"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/SHELLAC" />
        <resource>
            <Ingredient>
                <id value="SHELLAC" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="46N107B71O" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="46N107B71O"/>
								<display value="SHELLAC"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/AMMONIA" />
        <resource>
            <Ingredient>
                <id value="AMMONIA" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="5138Q19F1X" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="5138Q19F1X"/>
								<display value="AMMONIA"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/PROPYLENE_GLYCOL" />
        <resource>
            <Ingredient>
                <id value="PROPYLENE_GLYCOL" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="6DC9Q167V3" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="6DC9Q167V3"/>
								<display value="PROPYLENE GLYCOL"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/DIMETHICONE" />
        <resource>
            <Ingredient>
                <id value="DIMETHICONE" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="92RU3N3Y1O" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                    <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="92RU3N3Y1O"/>
								<display value="DIMETHICONE"/>
							</coding>
						</concept>
                </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/FERRIC-OXIDE-RED" />
        <resource>
            <Ingredient>
                <id value="FERRIC-OXIDE-RED" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="1K09F3G675" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                        <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="1K09F3G675"/>
								<display value="FERRIC OXIDE RED"/>
							</coding>
						</concept>
                    </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/MAGNESIUM-STEARATE" />
        <resource>
            <Ingredient>
                <id value="MAGNESIUM-STEARATE" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="70097M6I30" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                        <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="70097M6I30"/>
								<display value="MAGNESIUM STEARATE"/>
							</coding>
						</concept>
                    </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/MICROCRYSTALLINE-CELLULOSE" />
        <resource>
            <Ingredient>
                <id value="MICROCRYSTALLINE-CELLULOSE" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="OP1R32D61U" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                        <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="OP1R32D61U"/>
								<display value="MICROCRYSTALLINE CELLULOSE"/>
							</coding>
						</concept>
                    </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/palbociclib75" />
        <resource>
            <Ingredient>
                <id value="palbociclib75" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="G9ZF61LE7G" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="ACTIB" />
                        <display value="active ingredient - basis of strength" />
                    </coding>
                </role>
                <group>
                    <coding>
                        <system value="http://ncimeta.nci.nih.gov" />
                        <code value="N0000175605" />
                        <display value="Kinase Inhibitor" />
                    </coding>
                </group>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                        <reference>
							<reference value="SubstanceDefinition/palbociclib"/>
						</reference>
                    </code>
                    <strength>
                        <presentationQuantity>
                            <system value="http://unitsofmeasure.org" />
                            <value value="75" />
                            <unit value="mg" />
                            <code value="mg" />
                        </presentationQuantity>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/PALBOCICLIB100" />
        <resource>
            <Ingredient>
                <id value="PALBOCICLIB100" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="G9ZF61LE7G" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="ACTIB" />
                        <display value="active ingredient - basis of strength" />
                    </coding>
                </role>
                <group>
                    <coding>
                        <system value="http://ncimeta.nci.nih.gov" />
                        <code value="N0000175605" />
                        <display value="Kinase Inhibitor" />
                    </coding>
                </group>
                <description value="PALBOCICLIB 100mg" />
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                        <reference>
							<reference value="SubstanceDefinition/palbociclib"/>
						</reference>
                    </code>
                    <strength>
                        <presentationQuantity>
                            <system value="http://unitsofmeasure.org" />
                            <value value="100" />
                            <unit value="mg" />
                            <code value="mg" />
                        </presentationQuantity>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/PALBOCICLIB125" />
        <resource>
            <Ingredient>
                <id value="PALBOCICLIB125" />
                <identifier>
                    <use value="official" />
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="G9ZF61LE7G" />
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="ACTIB" />
                        <display value="active ingredient - basis of strength" />
                    </coding>
                </role>
                <group>
                    <coding>
                        <system value="http://ncimeta.nci.nih.gov" />
                        <code value="N0000175605" />
                        <display value="Kinase Inhibitor" />
                    </coding>
                </group>
                <description value="PALBOCICLIB 125mg" />
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                        <reference>
							<reference value="SubstanceDefinition/palbociclib"/>
						</reference>
                    </code>
                    <strength>
                        <presentationQuantity>
                            <system value="http://unitsofmeasure.org" />
                            <value value="125" />
                            <unit value="mg" />
                            <code value="mg" />
                        </presentationQuantity>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="SubstanceDefinition/palbociclib" />
        <resource>
            <SubstanceDefinition>
                <id value="palbociclib" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
                    <value value="9QHX048FRV" />
                </identifier>
                <version value="1" />
                <status>
                    <coding>
                        <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/" />
                        <code value="1" />
                        <display value="Validated (UNII)" />
                    </coding>
                </status>
                <name>
                    <name value="palbociclib" />
                </name>
            </SubstanceDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/SILICON-DIOXIDE" />
        <resource>
            <Ingredient>
                <id value="SILICON-DIOXIDE" />
                <identifier>
                    <coding>
                        <system value="http://fdasis.nlm.nih.gov" />
                        <value value="ETJ7Z6XBU4" />
                    </coding>
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
                        <concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="ETJ7Z6XBU4"/>
								<display value="SILICON DIOXIDE"/>
							</coding>
						</concept>
                    </code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="Ingredient/TITANIUM-DIOXIDE" />
        <resource>
            <Ingredient>
                <id value="SUCCINIC-ACID" />
                <identifier>
                    <coding>
                        <system value="http://fdasis.nlm.nih.gov" />
                        <value value="AB6MNQ6J6L" />
                    </coding>
                </identifier>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </for>
                <for>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" />
                        <code value="IACT" />
                        <display value="inactive ingredient" />
                    </coding>
                </role>
                <allergenicIndicator value="false" />
                <substance>
                    <code>
					<concept>
							<coding>
								<system value="http://fdasis.nlm.nih.gov"/>
								<code value="AB6MNQ6J6L"/>
								<display value="SUCCINIC ACID"/>
							</coding>
						</concept>
				</code>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="MID-PALBOCICLIB75" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0069-0187" />
                </identifier>
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C25158" />
                        <display value="CAPSULE" />
                    </coding>
                </manufacturedDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C48480" />
                        <display value="CAPSULE" />
                    </coding>
                </unitOfPresentation>
                <manufacturer>
                    <reference value="Organization/341970073" />
                </manufacturer>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48556" />
                            <display value="Structured Product Labeling Color" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48327" />
                            <display value="PURPLE" />
                        </coding>
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48557" />
                            <display value="Structured Product Labeling Shape" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48348" />
                            <display value="ROUND" />
                        </coding>
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLSIZE" />
                        </coding>
                    </type>
                    <valueQuantity>
                        <value value="10" />
                        <unit value="millimeter" />
                        <system value="https://unitsofmeasure.org" />
                        <code value="mm" />
                    </valueQuantity>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLIMPRINT" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <text value="Pfizer;PBC;75" />
                    </valueCodeableConcept>
                </property>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="MID-PALBOCICLIB100" />
                <identifier>
                    <coding>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0069-0188" />
                    </coding>
                </identifier>
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C25158" />
                        <display value="CAPSULE" />
                    </coding>
                </manufacturedDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C48480" />
                        <display value="CAPSULE" />
                    </coding>
                </unitOfPresentation>
                <manufacturer>
                    <reference value="Organization/341970073" />
                </manufacturer>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48556" />
                            <display value="Structured Product Labeling Color" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48329" />
                            <display value="GREEN" />
                        </coding>
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48557" />
                            <display value="Structured Product Labeling Shape" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48345" />
                            <display value="OVAL" />
                        </coding>
                        <text value="OVAL" />
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLSIZE" />
                        </coding>
                    </type>
                    <valueQuantity>
                        <value value="15" />
                        <unit value="millimeter" />
                        <system value="https://unitsofmeasure.org" />
                        <code value="mm" />
                    </valueQuantity>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLIMPRINT" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <text value="Pfizer;PBC;100" />
                    </valueCodeableConcept>
                </property>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="MID-PALBOCICLIB125" />
                <identifier>
                    <coding>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0069-0189" />
                    </coding>
                </identifier>
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C25158" />
                        <display value="CAPSULE" />
                    </coding>
                </manufacturedDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C48480" />
                        <display value="CAPSULE" />
                    </coding>
                </unitOfPresentation>
                <manufacturer>
                    <reference value="Organization/341970073" />
                </manufacturer>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48556" />
                            <display value="Structured Product Labeling Color" />
                        </coding>
                        <text value="COLOR" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48327" />
                            <display value="PURPLE" />
                        </coding>
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48557" />
                            <display value="Structured Product Labeling Shape" />
                        </coding>
                        <text value="SHAPE" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48345" />
                            <display value="OVAL" />
                        </coding>
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLSIZE" />
                        </coding>
                    </type>
                    <valueQuantity>
                        <value value="16" />
                        <unit value="millimeter" />
                        <system value="https://unitsofmeasure.org" />
                        <code value="mm" />
                    </valueQuantity>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLIMPRINT" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <text value="Pfizer;PBC;125" />
                    </valueCodeableConcept>
                </property>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
        <resource>
            <MedicinalProductDefinition>
                <id value="MPDPALBOCICLIB75" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0069-0187" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                        <code value="C38288" />
                        <display value="ORAL" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2015-02-03" />
                    </dateRange>
                </marketingStatus>
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C121840" />
                        <display value="Approved for Human Use Product" />
                    </coding>
                </type>
                <domain>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C14225" />
                        <display value="Human" />
                    </coding>
                </domain>
                <version value="1" />
                <status>
                    <coding>
                        <system value="http://hl7.org/fhir/publication-status" />
                        <code value="active" />
                        <display value="Active" />
                    </coding>
                </status>
                <statusDate value="2020-03-30" />
                <name>
                    <productName value="IBRANCEÂ® (palbociclib) Capsules - 75 mg" />
                    <part>
                        <part value="palbociclib" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C71898" />
                            </coding>
                            <text value="Proprietary Name" />
                        </type>
                    </part>
                    <part>
                        <part value="palbociclib" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C3273150" />
                            </coding>
                            <text value="NONPROPRIETARY" />
                        </type>
                    </part>
                    <part>
                        <part value="75 mg" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="220000000004" />
                            </coding>
                            <text value="Strength part" />
                        </type>
                    </part>
                    <part>
                        <part value="CAPSULE" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C25158" />
                                <display value="Pharmaceutical dose form part" />
                            </coding>
                        </type>
                    </part>
                    <countryLanguage>
                        <country>
                            <coding>
                                <system value="urn:iso:std:iso:3166" />
                                <code value="US" />
                                <display value="United States of America" />
                            </coding>
                        </country>
                        <language>
                            <coding>
                                <system value="urn:iso:std:iso:639" />
                                <code value="EN" />
                                <display value="English" />
                            </coding>
                        </language>
                    </countryLanguage>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/618054084" />
                    </organization>
                    <organization>
                        <reference value="Organization/985052076" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                    <organization>
                        <reference value="Organization/936889401" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/985052076" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                    <organization>
                        <reference value="Organization/936889401" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/618054084" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/134489525" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
        <resource>
            <MedicinalProductDefinition>
                <id value="MPDPALBOCICLIB100" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0069-0188" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                        <code value="C38288" />
                        <display value="ORAL" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2015-02-03" />
                    </dateRange>
                </marketingStatus>
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C121840" />
                        <display value="Approved for Human Use Product" />
                    </coding>
                </type>
                <domain>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C14225" />
                        <display value="Human" />
                    </coding>
                </domain>
                <version value="1" />
                <status>
                    <coding>
                        <system value="http://hl7.org/fhir/publication-status" />
                        <code value="active" />
                        <display value="Active" />
                    </coding>
                </status>
                <statusDate value="2020-03-30" />
                <name>
                    <productName value="IBRANCEÂ® (palbociclib) Capsules - 100 mg" />
                    <part>
                        <part value="palbociclib" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C71898" />
                            </coding>
                            <text value="Proprietary Name" />
                        </type>
                    </part>
                    <part>
                        <part value="palbociclib" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C3273150" />
                            </coding>
                            <text value="NONPROPRIETARY" />
                        </type>
                    </part>
                    <part>
                        <part value="100 mg" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="220000000004" />
                            </coding>
                            <text value="Strength part" />
                        </type>
                    </part>
                    <part>
                        <part value="CAPSULE" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C25158" />
                                <display value="Pharmaceutical dose form part" />
                            </coding>
                        </type>
                    </part>
                    <countryLanguage>
                        <country>
                            <coding>
                                <system value="urn:iso:std:iso:3166" />
                                <code value="US" />
                                <display value="United States of America" />
                            </coding>
                        </country>
                        <language>
                            <coding>
                                <system value="urn:iso:std:iso:639" />
                                <code value="EN" />
                                <display value="English" />
                            </coding>
                        </language>
                    </countryLanguage>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/618054084" />
                    </organization>
                    <organization>
                        <reference value="Organization/985052076" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                    <organization>
                        <reference value="Organization/936889401" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/985052076" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                    <organization>
                        <reference value="Organization/936889401" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/618054084" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/134489525" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
        <resource>
            <MedicinalProductDefinition>
                <id value="MPDPALBOCICLIB125" />
                <identifier>
                    <coding>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0069-0189" />
                    </coding>
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                        <code value="C38288" />
                        <display value="ORAL" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2015-02-03" />
                    </dateRange>
                </marketingStatus>
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C121840" />
                        <display value="Approved for Human Use Product" />
                    </coding>
                </type>
                <domain>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C14225" />
                        <display value="Human" />
                    </coding>
                </domain>
                <version value="1" />
                <status>
                    <coding>
                        <system value="http://hl7.org/fhir/publication-status" />
                        <code value="active" />
                        <display value="Active" />
                    </coding>
                </status>
                <statusDate value="2020-03-30" />
                <name>
                    <productName value="IBRANCEÂ® (palbociclib) Capsules - 125 mg" />
                    <part>
                        <part value="palbociclib" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C71898" />
                            </coding>
                            <text value="Proprietary Name" />
                        </type>
                    </part>
                    <part>
                        <part value="palbociclib" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C3273150" />
                            </coding>
                            <text value="NONPROPRIETARY" />
                        </type>
                    </part>
                    <part>
                        <part value="125 mg" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="220000000004" />
                            </coding>
                            <text value="Strength part" />
                        </type>
                    </part>
                    <part>
                        <part value="CAPSULE" />
                        <type>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C25158" />
                                <display value="Pharmaceutical dose form part" />
                            </coding>
                        </type>
                    </part>
                    <countryLanguage>
                        <country>
                            <coding>
                                <system value="urn:iso:std:iso:3166" />
                                <code value="US" />
                                <display value="United States of America" />
                            </coding>
                        </country>
                        <language>
                            <coding>
                                <system value="urn:iso:std:iso:639" />
                                <code value="EN" />
                                <display value="English" />
                            </coding>
                        </language>
                    </countryLanguage>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/618054084" />
                    </organization>
                    <organization>
                        <reference value="Organization/985052076" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                    <organization>
                        <reference value="Organization/936889401" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/985052076" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                    <organization>
                        <reference value="Organization/936889401" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/618054084" />
                    </organization>
                    <organization>
                        <reference value="Organization/341970073" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/134489525" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="AdministrableProductDefinition/APD-PALBOCICLIB75" />
        <resource>
            <AdministrableProductDefinition xmlns="http://hl7.org/fhir">
                <id value="APD-PALBOCICLIB75" />
                <identifier>
                    <coding>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0069-0187" />
                    </coding>
                </identifier>
                <subject>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </subject>
                <administrableDoseForm>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C25158" />
                        <display value="CAPSULE" />
                    </coding>
                </administrableDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C48480" />
                        <display value="CAPSULE" />
                    </coding>
                </unitOfPresentation>
                <producedFrom>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                </producedFrom>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48556" />
                            <display value="Structured Product Labeling Color" />
                        </coding>
                        <text value="COLOR" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48327" />
                            <display value="Purple" />
                        </coding>
                        <text value="PURPLE" />
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48557" />
                            <display value="Structured Product Labeling Shape" />
                        </coding>
                        <text value="SHAPE" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48348" />
                            <display value="Round" />
                        </coding>
                        <text value="ROUND" />
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLSIZE" />
                        </coding>
                        <text value="SIZE" />
                    </type>
                    <valueQuantity>
                        <value value="10" />
                        <unit value="millimeter" />
                        <system value="https://unitsofmeasure.org" />
                        <code value="mm" />
                    </valueQuantity>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLIMPRINT" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <text value="Pfizer;PBC;75" />
                    </valueCodeableConcept>
                </property>
                <routeOfAdministration>
                    <code>
                        <coding>
							<system value="http://ncit.nci.nih.gov"/>
							<code value="C38288"/>
							<display value="Oral Route of Administration"/>
						</coding>
                        <text value="ORAL"/>
                    </code>
                    <targetSpecies>
                        <code>
                            <coding>
								<system value="http://ncit.nci.nih.gov"/>
								<code value="C14225"/>
								<display value="Human"/>
							</coding>
                            <text value="HUMAN"/>
                        </code>
                    </targetSpecies>
                </routeOfAdministration>
            </AdministrableProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="AdministrableProductDefinition/APD-PALBOCICLIB100" />
        <resource>
            <AdministrableProductDefinition xmlns="http://hl7.org/fhir">
                <id value="APD-PALBOCICLIB100" />
                <identifier>
                    <coding>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0069-0188" />
                    </coding>
                </identifier>
                <subject>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </subject>
                <administrableDoseForm>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C25158" />
                        <display value="CAPSULE" />
                    </coding>
                </administrableDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C48480" />
                        <display value="CAPSULE" />
                    </coding>
                </unitOfPresentation>
                <producedFrom>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                </producedFrom>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48556" />
                            <display value="Structured Product Labeling Color" />
                        </coding>
                        <text value="COLOR" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48329" />
                            <display value="Green" />
                        </coding>
                        <text value="GREEN" />
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48557" />
                            <display value="Structured Product Labeling Shape" />
                        </coding>
                        <text value="SHAPE" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48345" />
                            <display value="Oval" />
                        </coding>
                        <text value="OVAL" />
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLSIZE" />
                        </coding>
                        <text value="SIZE" />
                    </type>
                    <valueQuantity>
                        <value value="15" />
                        <unit value="millimeter" />
                        <system value="https://unitsofmeasure.org" />
                        <code value="mm" />
                    </valueQuantity>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLIMPRINT" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <text value="Pfizer;PBC;100" />
                    </valueCodeableConcept>
                </property>
                <routeOfAdministration>
                    <code>
                        <coding>
							<system value="http://ncit.nci.nih.gov"/>
							<code value="C38288"/>
							<display value="Oral Route of Administration"/>
						</coding>
                        <text value="ORAL"/>
                    </code>
                    <targetSpecies>
                        <code>
                            <coding>
								<system value="http://ncit.nci.nih.gov"/>
								<code value="C14225"/>
								<display value="Human"/>
							</coding>
                            <text value="HUMAN"/>
                        </code>
                    </targetSpecies>
                </routeOfAdministration>
            </AdministrableProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="AdministrableProductDefinition/APD-PALBOCICLIB125" />
        <resource>
            <AdministrableProductDefinition xmlns="http://hl7.org/fhir">
                <id value="APD-PALBOCICLIB125" />
                <identifier>
                    <coding>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0069-0189" />
                    </coding>
                </identifier>
                <subject>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </subject>
                <administrableDoseForm>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C25158" />
                        <display value="CAPSULE" />
                    </coding>
                </administrableDoseForm>
                <unitOfPresentation>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C48480" />
                        <display value="CAPSULE" />
                    </coding>
                </unitOfPresentation>
                <producedFrom>
                    <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB125" />
                </producedFrom>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48556" />
                            <display value="Structured Product Labeling Color" />
                        </coding>
                        <text value="COLOR" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48327" />
                            <display value="Purple" />
                        </coding>
                        <text value="PURPLE" />
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48557" />
                            <display value="Structured Product Labeling Shape" />
                        </coding>
                        <text value="SHAPE" />
                    </type>
                    <valueCodeableConcept>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C48345" />
                            <display value="Oval" />
                        </coding>
                        <text value="OVAL" />
                    </valueCodeableConcept>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLSIZE" />
                        </coding>
                        <text value="SIZE" />
                    </type>
                    <valueQuantity>
                        <value value="16" />
                        <unit value="millimeter" />
                        <system value="https://unitsofmeasure.org" />
                        <code value="mm" />
                    </valueQuantity>
                </property>
                <property>
                    <type>
                        <coding>
                            <system value="urn:oid:2.16.840.1.113883.1.11.19255" />
                            <code value="SPLIMPRINT" />
                        </coding>
                    </type>
                    <valueCodeableConcept>
                        <text value="Pfizer;PBC;125" />
                    </valueCodeableConcept>
                </property>
                <routeOfAdministration>
                    <code>
                        <coding>
							<system value="http://ncit.nci.nih.gov"/>
							<code value="C38288"/>
							<display value="Oral Route of Administration"/>
						</coding>
                        <text value="ORAL"/>
                    </code>
                    <targetSpecies>
                        <code>
                            <coding>
								<system value="http://ncit.nci.nih.gov"/>
								<code value="C14225"/>
								<display value="Human"/>
							</coding>
                            <text value="HUMAN"/>
                        </code>
                    </targetSpecies>
                </routeOfAdministration>
            </AdministrableProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="PackagedProductDefinition/0069-0187-21" />
        <resource>
            <PackagedProductDefinition xmlns="http://hl7.org/fhir">
                <id value="0069-0187-21" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0069-0187-07" />
                </identifier>
                <name value="75 mg Capsule Bottle Label - 21 Capsules" />
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C43233" />
                        <display value="Drug Package" />
                    </coding>
                </type>
                <packageFor>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C53292" />
                            <display value="Marketing" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2015-02-03" />
                    </dateRange>
                </marketingStatus>
                <description value="NDC 0069-0187-21

                Pfizer
                
                IbranceÂ®
                (palbociclib)
                capsules
                
                75 mg
                
                21 Capsules
                
                Rx only" />
                <manufacturer>
                    <reference value="Organization/985052076" />
                </manufacturer>
                <manufacturer>
                    <reference value="Organization/341970073" />
                </manufacturer>
                <manufacturer>
                    <reference value="Organization/936889401" />
                </manufacturer>
                <packaging>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="NDC 0069-0187-21" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                            <code value="C43169" />
                            <display value="BOTTLE" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <shelfLifeStorage>
                        <periodQuantity>
                            <value value="48" />
                            <unit value="mo" />
                            <system value="https://unitsofmeasure.org" />
                            <code value="mo" />
                        </periodQuantity>
                        <specialPrecautionsForStorage>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C101707" />
                                <display value="Recommended Storage Temperature" />
                            </coding>
                            <text
                                value="Store IBRANCE at 68 Â°F to 77 Â°F (20 Â°C to 25 Â°C)." />
                        </specialPrecautionsForStorage>
                    </shelfLifeStorage>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB75" />
                        </item>
                        <amount>
                            <value value="21" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="1" />
                        </amount>
                    </containedItem>
                </packaging>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="PackagedProductDefinition/0069-0188-21" />
        <resource>
            <PackagedProductDefinition xmlns="http://hl7.org/fhir">
                <id value="0069-0188-21" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="NDC:0069-0188-03" />
                </identifier>
                <name value="100 mg Capsule Bottle Label - 21 capsules" />
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C43233" />
                        <display value="Drug Package" />
                    </coding>
                </type>
                <packageFor>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C53292" />
                            <display value="Marketing" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2015-02-03" />
                    </dateRange>
                </marketingStatus>
                <description value="NDC 0069-0188-21

                Pfizer
                
                IbranceÂ®
                (palbociclib)
                capsules
                
                100 mg
                
                21 Capsules" />
                <manufacturer>
                    <reference value="Organization/618054084" />
                </manufacturer>
                <manufacturer>
                    <reference value="Organization/341970073" />
                </manufacturer>
                <packaging>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="NDC:0069-0188-21" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                            <code value="C43169" />
                            <display value="BOTTLE" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <shelfLifeStorage>
                        <periodQuantity>
                            <value value="48" />
                            <unit value="mo" />
                            <system value="https://unitsofmeasure.org" />
                            <code value="mo" />
                        </periodQuantity>
                        <specialPrecautionsForStorage>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C101707" />
                                <display value="Recommended Storage Temperature" />
                            </coding>
                            <text
                                value="Store IBRANCE at 68 Â°F to 77 Â°F (20 Â°C to 25 Â°C)." />
                        </specialPrecautionsForStorage>
                    </shelfLifeStorage>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                        </item>
                        <amount>
                            <value value="21" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="1" />
                        </amount>
                    </containedItem>
                </packaging>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="PackagedProductDefinition/0069-0189-21" />
        <resource>
            <PackagedProductDefinition xmlns="http://hl7.org/fhir">
                <id value="0069-0189-21" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="NDC:0069-0188-07" />
                </identifier>
                <name value="125 mg Capsule Bottle Label - 21 capsules" />
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                        <code value="C43169" />
                        <display value="BOTTLE" />
                    </coding>
                </type>
                <packageFor>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C53292" />
                            <display value="Marketing" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2015-02-03" />
                    </dateRange>
                </marketingStatus>
                <description value="7 in 1 DOSE PACK; Type 0: Not a Combination Product" />
                <description value="NDC 0069-0189-21

                Pfizer
                
                IbranceÂ®
                (palbociclib)
                capsules
                
                125 mg
                
                21 Capsules
                
                Rx only" />
                <manufacturer>
                    <reference value="Organization/618054084" />
                </manufacturer>
                <manufacturer>
                    <reference value="Organization/341970073" />
                </manufacturer>
                <packaging>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="NDC:0069-0188-07" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncit.nci.nih.gov" />
                            <code value="C43192" />
                            <display value="Dose Pack" />
                        </coding>
                    </type>
                    <quantity value="1" />
                    <shelfLifeStorage>
                        <periodQuantity>
                            <value value="48" />
                            <unit value="mo" />
                            <system value="https://unitsofmeasure.org" />
                            <code value="mo" />
                        </periodQuantity>
                        <specialPrecautionsForStorage>
                            <coding>
                                <system value="http://ncit.nci.nih.gov" />
                                <code value="C101707" />
                                <display value="Recommended Storage Temperature" />
                            </coding>
                            <text
                                value="Store IBRANCE at 68 Â°F to 77 Â°F (20 Â°C to 25 Â°C)." />
                        </specialPrecautionsForStorage>
                    </shelfLifeStorage>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" />
                                <code value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference value="ManufacturedItemDefinition/MID-PALBOCICLIB100" />
                        </item>
                        <amount>
                            <value value="21" />
                            <system value="http://unitsofmeasure.org" />
                            <code value="1" />
                        </amount>
                    </containedItem>
                </packaging>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="RegulatedAuthorization/RA-PALBOCICLIB75" />
        <resource>
            <RegulatedAuthorization>
                <id value="RA-PALBOCICLIB75" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0069-0187-21" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C156642" />
                        <display value="Marketing Authorization" />
                    </coding>
                </type>
                <description
                    value="Pfizer - NDC 0069-0187-21 - IBRANCEÂ® (palbociclib) capsules - 75 mg - 21 capsules bottle" />
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" />
                        <code value="US" />
                        <display value="United States of America" />
                    </coding>
                </region>
                <status>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C121840" />
                        <display value="Approved for Human Use Product" />
                    </coding>
                </status>
                <statusDate value="2020-03-30" />
                <validityPeriod>
                    <start value="2020-11-01" />
                    <end value="" />
                </validityPeriod>
                <holder>
                    <reference value="Organization/134489525" />
                </holder>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="RegulatedAuthorization/RA-PALBOCICLIB100" />
        <resource>
            <RegulatedAuthorization>
                <id value="RA-PALBOCICLIB100" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0069-0188-21" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C156642" />
                        <display value="Marketing Authorization" />
                    </coding>
                </type>
                <description
                    value="Pfizer - NDC 0069-0188-21 - IBRANCEÂ® (palbociclib) capsules - 100 mg per capsule bottle" />
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" />
                        <code value="US" />
                        <display value="United States of America" />
                    </coding>
                </region>
                <status>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C121840" />
                        <display value="Approved for Human Use Product" />
                    </coding>
                </status>
                <statusDate value="2020-03-30" />
                <validityPeriod>
                    <start value="2020-11-01" />
                    <end value="" />
                </validityPeriod>
                <holder>
                    <reference value="Organization/134489525" />
                </holder>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="RegulatedAuthorization/RA-PALBOCICLIB125" />
        <resource>
            <RegulatedAuthorization>
                <id value="RA-PALBOCICLIB125" />
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0069-0189-21" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C156642" />
                        <display value="Marketing Authorization" />
                    </coding>
                </type>
                <description
                    value="Pfizer - NDC 0069-0189-21 - IBRANCEÂ® (palbociclib) capsules - 125 mg - 21 capsules bottle" />
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" />
                        <code value="US" />
                        <display value="United States of America" />
                    </coding>
                </region>
                <status>
                    <coding>
                        <system value="http://ncit.nci.nih.gov" />
                        <code value="C121840" />
                        <display value="Approved for Human Use Product" />
                    </coding>
                </status>
                <statusDate value="2020-03-30" />
                <validityPeriod>
                    <start value="2020-11-01" />
                    <end value="" />
                </validityPeriod>
                <holder>
                    <reference value="Organization/134489525" />
                </holder>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/1a2b3c4d-5e6f-7g8h-9i0j-1k2l3m4n5o6p" />
        <resource>
            <ClinicalUseDefinition>
                <id value="1a2b3c4d-5e6f-7g8h-9i0j-1k2l3m4n5o6p" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="CYP3AInhibitors001" />
                </identifier>
                <type value="interaction" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <interaction>
                    <interactant>
                        <itemCodeableConcept>
                            <coding>
                                <system value="https://example.com/system" />
                                <code value="CYP3AInhibitor" />
                                <display value="CYP3A Inhibitor" />
                            </coding>
                        </itemCodeableConcept>
                    </interactant>
                </interaction>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/2b3c4d5e-6f7g-8h9i-0j1k-2l3m4n5o6p7q" />
        <resource>
            <ClinicalUseDefinition>
                <id value="2b3c4d5e-6f7g-8h9i-0j1k-2l3m4n5o6p7q" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="CYP3AInducers002" />
                </identifier>
                <type value="interaction" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <interaction>
                    <interactant>
                        <itemCodeableConcept>
                            <coding>
                                <system value="https://example.com/system" />
                                <code value="CYP3AInducer" />
                                <display value="CYP3A Inducer" />
                            </coding>
                        </itemCodeableConcept>
                    </interactant>
                </interaction>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/3c4d5e6f-7g8h-9i0j-1k2l-3m4n5o6p7q8r" />
        <resource>
            <ClinicalUseDefinition>
                <id value="3c4d5e6f-7g8h-9i0j-1k2l-3m4n5o6p7q8r" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Midazolam003" />
                </identifier>
                <type value="interaction" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <interaction>
                    <interactant>
                        <itemCodeableConcept>
                            <coding>
                                <system value="https://precision.fda.gov/uniisearch/srs/unii/R60L0SM5BC" />
                                <code value="R60L0SM5BC" />
                                <display value="Midazolam" />
                            </coding>
                        </itemCodeableConcept>
                    </interactant>
                </interaction>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/4d5e6f7g-8h9i-0j1k-2l3m-4n5o6p7q8r9s" />
        <resource>
            <ClinicalUseDefinition>
                <id value="4d5e6f7g-8h9i-0j1k-2l3m-4n5o6p7q8r9s" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="HRHER2NegativeBreastCancer001" />
                </identifier>
                <type value="indication" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <indication>
                    <code>
                        <coding>
							<system value="http://snomed.info/sct"/>
							<code value="444615000"/>
							<display value="Hormone receptor-positive, HER2-negative advanced or metastatic breast cancer"/>
						</coding>
                    </code>
                </indication>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/6f7g8h9i-0j1k-2l3m-4n5o-6p7q8r9s0t1u" />
        <resource>
            <ClinicalUseDefinition>
                <id value="6f7g8h9i-0j1k-2l3m-4n5o-6p7q8r9s0t1u" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Neutropenia001" />
                </identifier>
                <type value="warning" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <warning>
                    <code>
                        <coding>
							<system value="http://snomed.info/sct"/>
							<code value="703938007"/>
							<display value="Neutropenia"/>
						</coding>
                    </code>
                    <description
                        value="Neutropenia was the most frequently reported adverse reaction in PALOMA-2 with an incidence of 80% and PALOMA-3 with an incidence of 83%." />
                </warning>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/7g8h9i0j-1k2l-3m4n-5o6p-7q8r9s0t1u2v" />
        <resource>
            <ClinicalUseDefinition>
                <id value="7g8h9i0j-1k2l-3m4n-5o6p-7q8r9s0t1u2v" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="ILD002" />
                </identifier>
                <type value="warning" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <warning>
                    <code>
                        <coding>
							<system value="http://snomed.info/sct"/>
							<code value="67782005"/>
							<display value="Interstitial lung disease"/>
						</coding>
                    </code>
                    <description
                        value="Severe, life-threatening, or fatal interstitial lung disease (ILD) and/or pneumonitis can occur in patients treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, including IBRANCE when taken in combination with endocrine therapy." />
                </warning>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/8h9i0j1k-2l3m-4n5o-6p7q-8r9s0t1u2v3w" />
        <resource>
            <ClinicalUseDefinition>
                <id value="8h9i0j1k-2l3m-4n5o-6p7q-8r9s0t1u2v3w" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="EmbryoFetalToxicity003" />
                </identifier>
                <type value="warning" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <warning>
                    <code>
                        <coding>
							<system value="http://snomed.info/sct"/>
							<code value="73761001"/>
							<display value="Embryo-Fetal Toxicity"/>
						</coding>
                    </code>
                    <description
                        value="Based on findings from animal studies and its mechanism of action, IBRANCE can cause fetal harm when administered to a pregnant woman." />
                </warning>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/1k2l3m4n-5o6p-7q8r-9s0t-1u2v3w4x5y6z" />
        <resource>
            <ClinicalUseDefinition>
                <id value="1k2l3m4n-5o6p-7q8r-9s0t-1u2v3w4x5y6z" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Anemia003" />
                </identifier>
                <type value="undesirable-effect" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <undesirableEffect>
                    <classification>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="271737000" />
                            <display value="Anemia" />
                        </coding>
                    </classification>
                    <frequency value="â¥10%" />
                </undesirableEffect>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/2l3m4n5o-6p7q-8r9s-0t1u-2v3w4x5y6z7a" />
        <resource>
            <ClinicalUseDefinition>
                <id value="2l3m4n5o-6p7q-8r9s-0t1u-2v3w4x5y6z7a" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Thrombocytopenia004" />
                </identifier>
                <type value="undesirable-effect" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <undesirableEffect>
                    <classification>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="302215000" />
                            <display value="Thrombocytopenia" />
                        </coding>
                    </classification>
                    <frequency value="â¥10%" />
                </undesirableEffect>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/2l3m4n5o-6p7q-8r9s-0t1u-2v3w4x5y6z7a" />
        <resource>
            <ClinicalUseDefinition>
                <id value="2l3m4n5o-6p7q-8r9s-0t1u-2v3w4x5y6z7a" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Thrombocytopenia004" />
                </identifier>
                <type value="undesirable-effect" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <undesirableEffect>
                    <classification>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="36225005" />
                            <display value="Blood and lymphatic system disorders" />
                        </coding>
                    </classification>
                    <symptomConditionEffect>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="302215000" />
                            <display value="Thrombocytopenia" />
                        </coding>
                    </symptomConditionEffect>
                    <frequency value="â¥10%" />
                </undesirableEffect>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/1k2l3m4n-5o6p-7q8r-9s0t-1u2v3w4x5y6z" />
        <resource>
            <ClinicalUseDefinition>
                <id value="1k2l3m4n-5o6p-7q8r-9s0t-1u2v3w4x5y6z" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Anemia003" />
                </identifier>
                <type value="undesirable-effect" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <undesirableEffect>
                    <classification>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="36225005" />
                            <display value="Blood and lymphatic system disorders" />
                        </coding>
                    </classification>
                    <symptomConditionEffect>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="271737000" />
                            <display value="Anemia" />
                        </coding>
                    </symptomConditionEffect>
                    <frequency value="â¥10%" />
                </undesirableEffect>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/0j1k2l3m-4n5o-6p7q-8r9s-0t1u2v3w4x5y" />
        <resource>
            <ClinicalUseDefinition>
                <id value="0j1k2l3m-4n5o-6p7q-8r9s-0t1u2v3w4x5y" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Leukopenia002" />
                </identifier>
                <type value="undesirable-effect" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <undesirableEffect>
                    <classification>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="36225005" />
                            <display value="Blood and lymphatic system disorders" />
                        </coding>
                    </classification>
                    <symptomConditionEffect>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="702760002" />
                            <display value="Leukopenia" />
                        </coding>
                    </symptomConditionEffect>
                    <frequency value="â¥10%" />
                </undesirableEffect>
            </ClinicalUseDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="ClinicalUseDefinition/9i0j1k2l-3m4n-5o6p-7q8r-9s0t1u2v3w4x" />
        <resource>
            <ClinicalUseDefinition>
                <id value="9i0j1k2l-3m4n-5o6p-7q8r-9s0t1u2v3w4x" />
                <meta>
                <profile
                    value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi" />
                </meta>
                <identifier>
                    <use value="official" />
                    <system value="https://example.com/system" />
                    <value value="Neutropenia001" />
                </identifier>
                <type value="undesirable-effect" />
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB75" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB100" />
                </subject>
                <subject>
                    <reference value="MedicinalProductDefinition/MPDPALBOCICLIB125" />
                </subject>
                <undesirableEffect>
                    <classification>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="36225005" />
                            <display value="Blood and lymphatic system disorders" />
                        </coding>
                    </classification>
                    <symptomConditionEffect>
                        <coding>
                            <system value="http://snomed.info/sct" />
                            <code value="703938007" />
                            <display value="Neutropenia" />
                        </coding>
                    </symptomConditionEffect>
                    <frequency value="â¥10%" />
                </undesirableEffect>
            </ClinicalUseDefinition>
        </resource>
    </entry>
</Bundle>